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In this work, the possibilities of understanding protein-drug interactions  
and the possible modes of action of the drug have been was explored using 
capillary isoelectric focusing (CIEF) and spectroscopic techniques. 
The first study involves the implementation and applications of the new 
high performance Raman spectrometer  with volume phase (VPH) based grating 
system,  which is integrated with a short  liquid-core optical waveguide for  
characterization and analysis of a wide ranges of molecules. The high 
performance Raman spectrometer has allowed us to measure solid samples with 
minor differences in chemical compositions. In addition, spectral characteristics 
of  the interactions between therapeutic drugs  with human serum albumin  have 
been examined in terms of the cleavage of  disulfide (S-S) bonds. The relative 
intensity of the Raman signal decrease as a complex formation progressed, 
suggesting perturbation around the disulfide bonds of human serum albumin 
(HSA). 
  This spectrometer is likely to be broadly applicable for simple to 
moderately complex samples. Furthermore, the future perspective of    
combining separation and spectroscopy technologies is a novel approach for 
capitalizing on the strengths of the  two technologies. 
            Capillary isoelectric focusing (CIEF) with whole column imaging 
detection (WCID) was used to investigate the interaction of platinum-based 
anticancer drugs, cisplatin and oxaliplatin, with human hemoglobin A0 (Hb) and 
HSA. This technique facilitates the investigation and characterization of the 
 iii
formation of adducts between drugs and proteins. At higher drug to protein 
molar ratios (for both oxaliplatin and cisplatin), the results exhibit significant 
changes in the peak shapes and heights, which may indicate the destabilization 
of the protein. However, the conformational change was less evident at lower 
molar ratios. In addition, a major pI shift was observed for the oxaliplatin 
reaction mixtures (for 1:10, 1:50 and 1:100 ratios). In comparison with 
previously reported findings obtained by other analytical methods, conclusions 
were drawn about the validity of CIEF as a simple and convenient method for 
the investigation of protein-drug interactions. These results may provide useful 
information for further understanding the activity and toxicity of these 
chemotherapeutic drugs and improving their clinical performance.  
         Spectroscopic evidence also shows that oxaliplatin causes  fluorescence 
quenching of HSA by formation of on HSA-oxaliplatin complex. The Stern-
Volmer equation has been used to calculate the quenching constant in the linear 
range. The quenching rate constants Kq at three different temperatures indicate 
the presence of a static quenching mechanism in the interactions of oxaliplatin 
with HSA. The work describes the validity of the CIEF-WCID technique for the 
study of protein-drug interactions and provides useful information and insight 
into the interaction of anti-cancer drugs with HSA concerning their further 





        Finally, a novel two-dimensional (2D) protein characterization using a 
single one dimensional separation followed by a second characterization in the 
same instrument was developed. The technique combines capillary isoelectric 
focusing ( CIEF), which separate proteins based on their isoelectric points, with 
a dynamic imaging focusing  and allows estimates of their  molecular weights 
from  measurement of their diffusion coefficients. This techniques applies to 
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1.1.1 Isoelectric Focusing 
Isoelectric focusing ( IEF)1 is an electrophoretic focusing technique by 
which amphoteric compounds (proteins, enzymes, peptides, etc ) are 
fractionated according to their isoelectric points (pI), which is directly related to 
the structure of the molecules and their acid–base properties along  continuous 
pH gradients 2-5.  IEF has become a valuable tool on account of its high 
resolving power for the separation of protein mixtures. The method has long 
been used to separate, isolate, purify and analyze a variety of proteins. 
Historically, this simple technique is carried out either in vertical 
polyacrylamide rod gels or in horizontal polyacrylamide or agarose slab gels. 
These gels are polymerized on a support film. In the beginning of  this technical 
innovation, sucrose concentration gradient columns in liquid phase was used to 
separate analytes 6. After the first application to the separation of proteins 
performed by Svensson 3,  it became a powerful analytical separation technique 
and was used routinely in  several research areas. The separation of amphoteric 
species is achieved efficiently by carrier ampholytes, which can generate a 
stable pH gradient throughout the separation gel when an electric field is 
applied to them.  Amphoteric species can carry positive, negative or zero charge 
depending on the electrical charge they experience when rubbed out on a gel.   
Basically the technique exploits the differences in pI of different amphoteric 
species. After a pH gradient is created in analytical agarose, sephadex or 
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polyacrylamide gels by carrier ampholytes, analytes are separated on the basis 
of their isoelectric points (pI), moving in the gel matrix to the pH where their 
positive charge balances their negative charge. During migration through the pH 
gradient, if a protein has a net negative charge, migration is toward the anode, 
and it thus encounters a lower pH, so that it picks up more positive charge.  The 
reverse happens when the protein has a net positive charge. Eventually, the 
protein will reach the point in the pH gradient where the net charge is zero. 
Therefore, at isoelectric point, the protein is uncharged, and since the migration 
ceases, it is focused in a narrow zone. After the protein is focused, any 
movement from the focused zone will gain a net charge and cause it to migrate 
back to the zone.  Hence, a dynamic equilibrium is established in the mass 
transport due to diffusion and electromigration. The following  differential 
equation describes the equilibrium between the electrophoretic and diffusional 
mass transport 3: 
 
                                    dxDdCEC /=μ                                             ( 1 ) 
 
where µ is the mobility (m2/Vs), C is the component concentration, D is the 
diffusion coefficient ( m2/s), E is the electric field strength (V/m),  and x is the 
distance along the focusing axis. Integration of the above equation leads to a 
Gaussian profile. Therefore, sharper bands are obtained if the diffusion 
coefficient is low. This equation also demonstrates the different mobility when 
pH=pI. If the analytes diffuse out from their pI toward the anode, it will gain a 
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positive charge and start to migrate to the cathode and refocus at pH=pI. The 
same phenomenon happens if the analyte gains a negative charge. Thus, for a 
sharp band, the refocusing process should be faster than the rate of diffusion.  
 
        IEF demonstrates a higher resolution than other modes of electrophoresis.  
The resolution of IEF is determined by the slope of the pH gradient and the 
electric field applied.  It has been demonstrated that proteins differing by 
0.001pI can be separated by IEF. 7 However, routinely IEF provides a resolution 
of 0.1 to 0.01 pI units.  For this technique, proteins (including enzyme isoforms, 
polyclonal and monoclonal antibodies, hemoglobin variants, and recombinant-
DNA proteins), viruses, bacteria and peptides are most exclusively the samples 
which are characterized by IEF, due to their amphoteric nature generated by the 
presence of carboxylic and amino groups.   
 
         It is important to realize that IEF technique has several limitations:  the 
precipitation of proteins at their pI and their intolerance of salt. Since 
amphoteric species have no charge and are electrically neutral at the pI point, 
the possibility of precipitation is very high at the pI point. High molecular 
weight proteins are highly susceptible to precipitation. Salt also interferes with 
the smooth gradient formation and the conductivity of the medium, due to the 





1.1.2 Carrier Ampholytes 
Carrier ampholytes (CA) are a mixture of specially designed low 
molecular mass polyamino-polycarboxylic acids with slightly different pI 
values.  These molecules exist as either anions or cations depending on the 
surrounding environment.   When carrier ampholytes are subjected to an 
electrical field, the molecules rearrange in such a way that the lowest pIs 
migrate to the anode and those with the highest pIs move to the cathode, thus 
producing a smooth pH gradient.   The carrier ampholytes continue to move 
through the capillary until each one reaches a place in the capillary where the 
pH of the solution equals the pI of the ampholyte; then a steady state is 
achieved. According to Svensson, a good carrier ampholyte should meet the 
following criteria:  the isoionic solutions of these molecules should show a good 
buffering capacity, conduct in their isoelectric state, so that they can carry 
electric current and maintain the pH gradient and be highly soluble in water.     
In early work by Svensson 3, 8 , he clearly defined the  requirements to make IEF 
a valuable technique to fractionate proteins. However, he could not find the 
appropriate compounds in the available catalogues to meet all the criteria he 
outlined in his theoretical work.  Instead,  Vesterberg 8 first had the idea of 
random polymerization of pentaethylene hexamine with acrylic acid to produce 
a complex mixture of amino-oligocarboxylic acids which demonstrate the 
characteristics defined by Svensson. Since the mixture of these CA permits the 
establishment of  pH gradients over a large pH range, CA contains from 50-
1000 species per pH unit are in order to create a linear pH gradient 9. 
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Furthermore, at least 30 ampholytes per pH unit are required in order to achieve 
a smooth pH gradient. Because of this large number of components with 
isoelectric points ranging from pH 3-10, many amphoteric analytes can be 
separated.   However, the usual practice in the laboratory is to keep the 
concentration of the carrier ampholytes between 1 and 2%. The practical work 
was first performed by Vesterberg and Svensson 10 while the mathematical 
explanation was first reported by Hjerten  11. 
 
1.1.3 Capillary Isoelectric Focusing 
IEF is a high resolution separation mode for the separation and analysis 
of  amphoteric biomolecules on the basis of differences in their isoelectric 
points in an electric field. This powerful technique has been used since the first 
paper published by Svensson in 19613. The method has long been used to 
separate, isolate, purify and analyze a variety of proteins. However, these 
methods are limited by a number of factors such as Joule heating, difficulty in 
quantification, and the time and labour required for analysis. Joule heating 
refers to the rising of temperature inside the separation column due to the 
application of an electric field.   The development of capillary electrophoresis 
(CE) paved the way to the performing of IEF in a capillary. Then Hjerten and 
coworkers introduced IEF in a capillary format (CIEF)11-14 in attempting to 
overcome the drawbacks with  conventional gel IEF techniques. As in gel IEF, 
CIEF is a CE separation technique for proteins and peptide based on differences 
in isoelectric point (pI), and is characterized by high resolution and spontaneous 
focusing of analytes. This technique can be used also for the determination of 
 5
isoelectric point of proteins. Capillary isoelectric focusing (CIEF) combines the 
high resolving power of conventional gel IEF with the automation and 
quantization advantages of capillary electrophoresis instrumentation. CIEF is 
also advantageous in terms of requirement of small sample volume, effective 
Joule heat dissipation and real-time data acquisition.  The narrow diameter 
capillary is responsible for the use of minute samples for analysis.  The use of a 
narrow capillary can greatly reduce the Joule heating generated by the 
electrophoresis process. In CIEF, the entire capillary (50 to 100 µm) is initially 
filled with a solution containing the analyte of interest and carrier ampholytes; 
the carrier ampholytes establish a pH gradient within the capillary column 
during the focusing process.   Before the focusing begins, one end of the 
capillary is immersed in a vial containing an anolyte solution (typically 
phosphoric acid) and the other in a catholyte solution (typically sodium 
hydroxide). Normally 0.02 M of phosphoric acid (H3PO4) and sodium 
hydroxide (NaOH) are used for the CIEF separation. The pH of phosphoric acid 
should be lower than the pI of the most acidic protein ( ampholyte), and the pH 
of sodium hydroxide is higher than the pI of the most basic ampholytes. Thus, 
during the focusing process, the two extreme buffers prevent the ampholyte 
from exiting through the two ends of the capillary.  
 
When proteins are carried through a capillary, under the influence of an 
electric field, electro-osmotic flow can interfere with the focusing procedure. 
Electro-osmotic flow (EOF) is caused by the absorption of analytes onto the 
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capillary wall. Since the surface of bare fused silica contains silanol (Si-OH) 
groups, when an acidic analyte passes through the capillary, the silanol group is 
ionized to negatively charges silanoate (Si-O-) groups. These negatively charged 
groups attract a positively charged group of the analyte of interest. However, the 
positively charged group attracted by the silanoate group is not enough to 
neutralize all the silanoate group so that a loose second layer is formed which 
attracts the opposite charge of the analyte-buffer composition.  Thus, when an 
electric field is applied, this positively charged mobile layer (loosely attached to 
the capillary wall) is, attracted to the cathode, thus causing electro-osmotic 
flow.  In CIEF, the presence of   electro-osmotic flow  interferes with the 
focusing process by  causing zone broadening (distortion) and the formation of 
multiple peaks due to the incomplete formation of focusing of the nascent bands 
at both capillary ends 15.Therefore, the coating of the capillary  before being 
used for separation can reduce the analyte-wall interaction and thus EOF.  Since 
most of the CIEF separation is conducted in a small diameter capillary, the 
possibility of adsorption on the wall of the capillary is higher. At least two 
coating techniques have been recommended and implemented to overcome 
EOF: dynamic coating and chemical coating. Typically in dynamic coating, a 
coating agent such as a polymer  or additives rinse through a capillary are mixed 
with the running buffer 16. Since coating agents such as polymers bind strongly 
to the silica surface, the column coated with polymer shows great stability 17. 
Unlike dynamic coating, chemical coating (permanent wall coating) required 
three steps : capillary pretreatment, introduction of double bonds to the capillary 
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wall, and binding of a polymer to the intermediate layer 17. In the first step , the 
column etching using concentrated sodium hydroxide  is followed by leaching 
with hydrochloric acid 18. Then the column is coated by attaching a polymer by 
using a reactive bifunctional silane such as γ-methacryloxy propyl trimethoxy 
silane to the surface of  the capillary. Finally the attachment of a polymer is 
achieved by using a free radical polymerization reaction with the established 
reactive olefinic sublayer on the silica surface. Even though this method shows 
variability in the coating thickness due to the formation of unreacted monomer 
residues , Righetti and co-worker resolved this problem by adding 3% short 
chains of polyacrylamide to the running buffer19.The other  potential parameter 
contributing to good reproducibility is making a fresh solution of electrolyte, 
specially sodium hydroxide, which can absorb carbon dioxide if  there it 
exposure  to air  which interferes with the focusing process 20. 
 
The ampholyte composition is selected to achieve the desired resolution. 
For instance, for complex samples with a wide distribution of isoelectric points, 
a broad range of ampholyte (pH 3-10) is typically used.    When a voltage is 
applied, the analyte of interest and carrier ampholytes migrate through the 
capillary until they reach a point where their charge is neutral (pI). At this point 
the separation current decreases significantly which indicates that the system 
has reached a steady state.  The decrease in the current is due to the depletion of 
charge carriers as the protein is close to the pI point. 
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The resolving power for two species can be defined as follows 10: 






=Δ                                                  ( 2 ) 
where D is the diffusion coefficient of the focused bands, E is the field strength, 
µ is the mobility of the protein,  dµ/dpH expresses the mobility-pH relationship, 
and dpH/dx expresses the relationship between the changes of buffer pH per 
unit of capillary length. This equation shows how the resolution is increased by 
selecting an appropriate ampholyte pH range 2. In the experiment the two 
variables ( E and dpH/dx) can be manipulated in order to optimize the 
resolution.  Higher voltage invokes an increased resolution and a narrow pH 
gradient leads to the same result. The other variables which are intrinsic to the 
sample are the diffusion coefficient and the rate of change of the mobility of the 
sample near its isoelectric point.  It is apparent that a low diffusion coefficient 
and a  large change of mobility with pH is desirable for higher resolution 2. In 
addition, an ampholyte with a narrow pH range is selected to maximize the 
resolution. However, to separate wide pI ranges of analytes, broad ranges of 
ampholyte or mixtures of several ampholytes are typically used. If all the other 
parameters are well optimized, a resolution of 0.02pH unit can be obtained for 
the separation of amphoteric species.  
 
The theoretical calculation of  the isoelectric point for a simple amino 
acid can be obtained by averaging the two pK values: 
                                   )(
2
1
ji pKpKpI +=                                                      ( 3 ) 
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where Ki and Kj are the dissociation constants of the two ionizations involving 
the carboxy and amino groups. For instance,( the amino acid glycine (Gly)), the 
isoelectric point of (Gly) can be calculated by averaging its two pK values. The 
pK of the carboxylic acid of Gly is 2.35 and the amino group is 9.78, thus 
yielding a pI of glycine (2.35 + 9.78)/2 = 6.07. 
                                       
However, when the molecules contain several basic and acidic groups such as 
large peptides and proteins,  the following equation must be used to estimate the 
pI21:  
 




















                 ( 4 ) 
 
where  the molecule has i weakly basic groups ( N-terminus)  and j weakly 
acidic groups. Typically , i=4 arising from the N-terminus group, which 
includes  the ε-amino group of  lysine, the guanidinium group of Arg and the 
imidazole group of histidine and j=5, arising from the C-terminus 
 ( α-carboxylic) group , which includes, the β-carboxyl group of aspartic acid, γ-
carboxyl of a glutamic acid, the phenolic group of tyrosine and the thiol of 
cysteine. This equation assumes that the dissociation constant, K,  are the same 
for all side chains on the polypeptide or protein. 
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The CIEF method can be considered as complementary to IEF rather 
than a competitive technique, because the method exhibits specific ranges of 
applicability, with advantages and disadvantages. Even though the CIEF 
technique provides extremely high separation efficiency, quantitative 
information is chiefly provided by other techniques. The two disadvantages of 
this technique are protein precipitation at the pI and salt intolerance.  
 
1.1.3.1Two-step CIEF 
Every commercial CE instrument is equipped with an on-line detection 
technique at a fixed point along the capillary22. Thus, it is necessary to have a 
method to transport the focused analyte zones toward the detection point and to 
pass to the detection window. This focusing and mobilization technique is 
called a two-step procedure. Three different techniques have been used to 
mobilize the focused bands: chemical, hydraulic and electro-osmotic 
mobilization techniques12, 23. In chemical mobilization, the chemical 
composition of anolyte or catholyte solution is replaced with a solution of 
neutral salt such as NaCl, acid or base in one of the vials, after the separation 
voltage is turned off, which occurs when the drop off of the current is observed. 
This shows the completion of the focusing process. The choice of the anodic or 
cathodic mobilization and the choice of mobilizing agents depend on the analyte 
of interest and its pI point. Typically, proteins have isoelectric points between 5 
to 10, thus mobilization toward a cathode is more practical 24. 
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The most common mobilization technique is the addition of NaCl to the 
anolyte or catholyte vials. Usually solutions of H3PO4 (10 to 20 mM) and 20 to 
40 mM of NaOH are used as anolyte and catholyte respectively. When the 
mobilization process is initiated, sodium serves as the non-proton cation in 
anodic mobilization, while chloride ion functions as the non-hydroxyl anion in 
cathodic mobilization. At the initial stage of the mobilization, the current stays 
low but gradually increases as the chloride ion enters the capillary. Similar to 
the focusing process, the mobilization applied electrical field ranges from 300 to 
1000V/cm. Once the chloride ions are distributed throughout the capillary, the 
mobilization current starts to rise rapidly which indicates the end of the 
mobilization process. This process was first described by Hjerten et al 11 with 
the   following equation: 
                        ∑∑ −−++ +=+ COOOHNHH CCCC 3                    ( 5 ) 
where CH+ is the concentration of protons, COH- hydroxyl ions, CNH3+, CCOO- 
are  positive and negative groups  in the ampholytes, respectively 11. For anodic 
mobilization, the non-proton reagent added to the anode, expands the left side of 
equation 5 by introducing an  Xn+ term. Thus, the above equation can be 
rewritten as follows: 
 
             ∑∑ −−+++ +=+ COOOHNHHX CCCCC n 3                  ( 6 ) 
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However, if the salt (anion) is added to the catholyte, the above expression 
becomes 
 
             −−−+ ++=+ ∑∑ + mYCOOOHNHH CCCCC 3                    ( 7 ) 
where CYm- is an anion with valence m-. The added salt competes with OH- for 
electromigration to the separation capillary. For this reason a few hydroxyl ions 
enter the capillary, and as a result, the pH decreases. Similarly, the addition of 
non-proton cations into the capillary cause the pH to increase due to the 
reduction of  proton concentration. 
The other mobilization technique is hydraulic mobilization. In this 
technique, the focused bands move past the detector by physical means  
( pumped or aspirated).  During hydraulic mobilization, band broading  is 
avoided by applying the focusing voltage during the elution. The advantage of 
leaving the focusing voltage during the mobilization is to maintain the 
resolution of the focused band 24.   
 
The quest for a simple (one step) mobilization drives researchers to find 
an alternative technique, which applies without impairing the resolution of the 
focused band. The electro-osmotic mobilization technique is one which is often 
used. In this approach, EOF  is used to mobilize the focused band 25. The 
mobilization procedure can be applied to both coated and uncoated separation 
capillaries. 
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1.1.3.2 Single-step CIEF 
In single-step CIEF, focusing and mobilization steps occur 
simultaneously. In this mobilization technique, the whole content of the 
capillary moves to the detector, while focusing occurs simultaneously 25. After 
the capillary is filled with the sample of interest, the capillary is placed between 
the catholyte and anolyte, and an electrical field is applied to focus the analytes. 
Meanwhile, the focused bands are swept to the detector using EOF. Both coated 
and uncoated capillaries can be used for the single step CIEF method. 
 
1.1.3.3 Whole Column Imaging Detection 
Capillary isoelectric focusing ( CIEF)  is a CE separation technique for 
proteins and peptides based on differences in isoelectric point (pI)  and is 
characterized by high resolution and spontaneous focusing of analytes . 
Analytes focus into narrow zones at different positions inside the capillary 
corresponding to their different pI values. Normally CIEF is performed using a 
common CE instrument with a 20- 50 cm long capillary with a single-point and 
on-column detection system.  Eventually, the focused bands are mobilized to 
pass through the column to the detection point. The  mobilization process can be 
accomplished by electrophoretic force, hydrodynamic flow, or electro-osmotic 
flow techniques .  However, this traditional mobilization technique has some 
limitations associated with the mobilization process.  Some of the limitations 
include the following: it takes longer time for the focused bands to move to the 
detection window 11, 12; once a sample is injected into the separation column,  
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the separation process, peak broadening, sample absorption and the dynamics of 
the focusing cannot be monitored with the traditional detection techniques. In 
order to resolve these drawbacks, a new method called  whole column imaging 
detection (WCID) was developed in our laboratory.   Whole column imaging 
detection (WCID)26-30 is an attractive detection scheme for CIEF measurement. 
In CIEF–WCID, unlike single point detection, amphoteric analytes are focused 
into narrow stationary bands, followed by imaging detection with a CCD 
camera. As WCID eliminates the mobilization step required by the conventional 
single point detection, CIEF–WCID possesses three advantages over single 
point detection. First, the inherent characteristics of CIEF (high efficiency and 
high resolution) are maintained. Second, the optimization of separation 
conditions is simplified and the total separation time is greatly reduced. Third, 
the CIEF profiles at different focusing times can easily be obtained, which is 
suitable for dynamic monitoring of protein–protein and protein–drug 
interactions. Due to  the growing interest in the separation science for such a  
unique technique, CIEF–WCID has found applications in the separation and 
characterization of small molecules 31, peptides 32, 33, proteins 32-34, antibodies 33, 
35, viruses 35-37and cells 38. It has been demonstrated to be a powerful tool for the 
study of reactions of proteins 39, rapid two-dimensional characterization of 





1.2  Detection Techniques 
In capillary electrophoresis, the common detection technique is UV/vis 
absorbance due to its ease of operation. This technique is easily adapted from 
high performance liquid chromatography (HPLC). In general, the most common 
detectors in CE are UV/vis absorbance, fluorescence (direct and indirect), laser-
induced fluorescence, mass spectrometry, conductivity, amperometry  
(direct and indirect), radiometry and refractive index measurement. Several 
criteria should be fulfilled when a detector is used for sample analysis. Such 
criteria include sensitivity, linear dynamic range, selectivity, low noise and the 
ability to provide qualitative data 20. 
 
1.2.1 UV/Vis Detection 
UV-absorbance detection is the most widely used and the choice for  the 
CE technique11, 12, 41. This detection scheme is very popular so that almost all 
commercial instruments are equipped with UV/Vis detector.  Light of intensity 
IIn from a source (lamp) is imaged on a capillary, where the sample absorbs 
some of the light.  The transmitted intensity (Iout) from the capillary is detected 
with a photomultiplier tube or silicon photodiode. This transmitted intensity is 
then converted to an absorbance value : 
T = Iout/IIn                                                                                ( 8 ) 
where T is the transmittance. 
There are different light sources used in absorbance detectors. These include 
broad band light produced from xenon and arc lamps.  In HPLC, absorbance 
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detection at 280nm is typically used to monitor sample separation. Thus, the 
development of the CE detector is attributed to the ease of adaptation from the 
HPLC detector. For CE application, a high quality fused-silica capillary is 
necessary, since fused silica has a UV cutoff of approximately 170 nm 42.  This 
detection scheme is popular because no derivatization is needed. However, 
although UV/Vis is the choice of detection for several applications, this 
detection scheme is limited by the available path length and concentration 
sensitivity. For example, for some biologically active  molecules , the 
concentration is too low (10-11 to 10-13mol/L)43 to detect by CE using an UV/Vis 
detector. A possible approach is to use a light source with high intensity and a 
better focus. 
 
1.2.2 Fluorescence Detection 
  Fluorescence is the second most  popular detection method implemented 
in the CE technique 44.  Fluorescence provides high sensitivity and extremely 
low limits of detection for analytes separated by CE, but the technique  gives 
little structural or diagnostic information. The choice of excitation sources is 
lamp or laser depending on the application of interest. Even though laser 
radiation is not available in a broad range of wavelengths (tunable lasers are still 
expensive), one can use continuous wave laser.   In a capillary, although the 
amount of light absorbed is affected by the path length as in UV/Vis, the 
decrease in fluorescence intensity can be compensated by increasing the laser 
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power. This highly selective and sensitive technique is especially important for 
biological applications.  
 
1.3 Vibrational Spectroscopy 
Vibrational spectroscopy has been well established as a useful tool for 
the analysis of organic and inorganic substances, whether of biological, 
geological or synthetic origin. The vibrational spectroscopy of molecules can be 
determined by two spectroscopic techniques: infrared 45 and Raman 
spectroscopy46. These two complementary techniques are well established for 
studies of the vibrational properties of molecules in gas, liquid and solid phases. 
The study of  molecular vibrational frequencies , vibrational intensities, line 
shape/width, polarization of IR and Raman modes, and potential energy 
surfaces ( force constants) are important for understanding  several physical 
properties of  molecules47, 48. The information content of both techniques are 
complementary and equally important for the vibrational analysis of molecules, 
and is information that can be used for both qualitative and quantitative 
purposes. Infrared and Raman both depend on the interaction of electromagnetic 
radiation with molecule. However, the physical interaction of matter with 
electromagnetic radiation is different in the two techniques. In infrared 
spectroscopy, absorption occurs when the frequency of the incident radiation 
matches the vibrational frequency of a particular mode of vibration. Molecules 
are promoted to  vibrational excited states after the energy is absorbed. IR 
activity is usually associated with changes in the dipole moment of the molecule 
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related to the vibrational motion. For infrared spectroscopy, the radiation covers 
a wide range of infrared energy.   In contrast, in Raman spectroscopy the sample 
is irradiated with a single wavelength source, and the scattered photons from the 
sample are captured by an appropriate detector.  Raman scattering rises from the 
distortion (changes in polarizability), of electron clouds around the nuclei after 
light interacts with a molecule. The IR and Raman activity of a given vibration 
also depends on the symmetry of the species.  
 
  Molecular vibrations can range from a simple oscillation of the two 
atoms in diatomic molecules to much more complex motions in polyatomic 
molecules. Each atom in a molecule has three degrees of freedom since it can 
move independently along the axes of a Cartesian coordinate system. If n atoms 
constitute a molecule, the 3n total degrees of freedom define the form of its 
normal modes. Normal modes are a set of collective atomic  displacements 
which may be superimposed to describe the overall vibrational motion of a 
molecule49. Three of these modes are involved in the translation of the entire 
molecules along the x, y and z-axes and the another three degrees of freedom 
involve the rotations of a molecule about the three principal axes of inertia. The 
remaining vibrational degrees of freedom ( vibrational modes), are responsible 
for distance changes between atoms, such as the length of chemical bonds and 
the angles between them. Thus, for a non-linear molecule, the number of 
fundamental vibrational modes is , 3n-3-3=3n-6 and for a linear molecule, the 
number of modes is 3n-3-2 = 3n-5 since linear molecules have only two 
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rotational degree of freedom, because the moment of inertia along the molecular 
axes is zero50-54.  
 
The simplest way to describe and approximate the vibrational motion of 
a diatomic molecule is the cartoon picture of two masses ( m1 and m2) attached 
with an elastic spring (Fig 1-1).  
 
 
Figure 1-1. The harmonic approximation for a diatomic molecule. 
 
This model will oscillate about the equilibrium position with  proportional to the 
force constant f . 
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                                   frForce −=                                                   ( 9 ) 
f is a force constant,  which is a measure of the strength of the bond and r is the 
displacement from eqilibrium. Since force equals mass times acceleration, 
equation 9 becomes 55: 














−= μ                  ( 10 ) 
where  µ = m1m2/(m1+m2) is the reduced mass of diatomic molecule  and t 
represents time. The solution of the above second order differential equation is: 
 
                                       )2cos(0 θπν += trr                                    ( 11 ) 
 where ν is vibrational frequency and θ the phase angle. Equation 11 describes 
the motion of the atoms as a harmonic oscillation.  Finally we obtain the 
equation to describe the frequency of the vibrations of diatomic molecule: 
 






1                                        ( 12 ) 
Where ν is the frequency of the vibration and  is  the wavenumber, measured 
in cm-1 .In vibrational spectroscopy, it is a common practice to use wavenumber 
units instead of  frequencies. 
 
1.3.1 Raman Spectroscopy 
The first experimental Raman effect was discovered by  Raman and 
Krishnan in 192846. Before the experimental discovery of Raman scattering, 
several groups had predicted the Raman phenomenon. Historically, Raman 
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spectroscopy has been difficult to perform due to the high level of instrumental 
complexity. However, the continuing advance and improvement of lasers, 
highly sensitive detectors, holographic filters and the modern commercialization 
of the Raman system make this technique as useful and practical as infrared 
spectroscopy. 
 
Raman scattering is used to obtain information about the structure and 
physical properties of the vibrational energy of a molecule. Since  every 
compound has a unique spectral fingerprint, and  since no two molecules give 
exactly the same Raman spectrum, and since the intensity of the scattered light 
is related to the amount of material present, it is easy to obtain both qualitative 
and quantitative information about a sample. 
 
The Raman effect has a low photon scattering efficiency since only 
about 1 in 107 incoming photons interact inelastically with a molecule.  The 
Raman activity arises from interactions of the electric field of electromagnetic 
radiation with electrons and when the nuclei start to move at the same time. The 
incident electromagnetic field will induce an oscillating dipole (µ), which will 
re-emit (scatter) at the frequency of the dipole oscillation. The light scattered by 
the induced dipole consists of both Raleigh (elastic) and Raman (inelastic) 
scattering. Raleigh scattering corresponds to scattered light which has exactly 
the same energy (frequency) as the original incident radiation, whereas the 
scattering from the light-induced oscillation from the electron cloud is called 
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Raman scattering.  The intensities of Raleigh and Raman scattered light is 
directly proportional to the number of molecules exposed to the electromagnetic 
radiation. In Raman scattering, the incident photon causes the energy of the 
molecule to increase from ground state to the ‘virtual state’ and form a complex. 
This complex formation is very short lived and not stable, and the energy is 
released as scattered radiation. Hence, the Raman radiation is shifted in 
frequency (energy) from the frequency of the incident radiation.  
 
  A simple classical electromagnetic description of Raman scattering can 
be used to obtain a basic understanding of the scattering properties of 
molecules. The simplest way to understand the Raman mechanism is to use an 
energy level diagram as shown in Fig.1-2. This energy level diagram illustrates 
that the energy difference between the scattered photons and the incident 
photons occurs as the result of coupling between the incident radiation and the 
quantized states of the scattering molecule. The energy difference between the 
incident and scattered photons is represented by arrows of different lengths. 
Incident photons either lose energy (Stokes shift) or gain energy (anti Stokes 
shift) when they interact with a target molecule.  Generally, the intensity of the 
anti-Stokes Raman spectrum is weaker than the Stokes-shifted spectrum, as 
anti-Stokes scattering occurs from the excited states (ν=1). According to the 
Boltzmann distribution these are less populated than the ground states (ν=0) at 
room temperature. In general, Raman scattering is usually assumed to be Stoke 




Figure 1-2. Energy level diagram showing the basic transitions involved in 
Raman scattering of a vibrational  energy level of hνk, when excited by energy 
of hν0.The virtual state is  lower in energy than a real electronic transition. 
 
1.3.1.1Theoretical Overview 
The classical treatment of Raman scattering is based on the concept that 
scattered light is generated by oscillating electric dipoles induced by the electric 
field of incident radiation.  When electromagnetic radiation is incident upon a 
molecule, the induced electric field is described by the following equation: 
 
                               tEE 00 2cos πν=                                                      ( 13 ) 
where E is the time-dependent amplitude, E0 is the maximum amplitude , and ν0 
is  the frequency of the laser light. When this field interacts with a molecule, it 
induces a  dipole µ such that 
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                           tEE πνααμ 2cos0==                                      ( 14 ) 
where α is a constant proportionality ( 3 x 3 tensor) called polarizability. The 
molecular polarizability depends on the cloud of electrons surrounding the 
central nucleus, that changes with normal coordinates during the vibrations of a 
molecule. According to classical electromagnetic theory, a dipole oscillating 
with frequency ν emits radiation of this frequency, with an intensity given by 50: 





I R =                                                 ( 15 ) 
Where µ0 is the amplitude of µ. In equation 15, the scattered light has the same 
frequency as the incident. The induced dipole moment in equation 15 can be 
written in terms of Cartesian components if we restrict our discussion to the 
linear term of the equation. The three forms of the linear equations are as 
follows: 
 













                                    ( 16 ) 
 
where  ijα  are the components of polarizability  of the molecule , and the first 
subscript i refer to the direction of the induced dipole in  the molecule, and the 
second subscript j refer to the polarization of  the incident light. The above 
equation can be rewritten as a matrix equation as µ=αE. Thus, the polarizability 
of the molecule is a tensor. 
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For almost every case, the polarizability tensor can be described by a real 
symmetric matrix where αij = αji, etc. Thus it has at most 6 independent 
components: 3 diagonal and 3 off-diagonal. This matrix is necessarily 
symmetric only in the case of non-resonant Raman scattering. 
 
Now let the scattering body be not just a polarizable sphere but possessing 
vibrational modes of its own; the normal mode Q is described by  
 
                                                                        ( 18 ) tQQ kkk πν2cos0=
The modulation of the polarizability of a molecule is affected by the oscillation 
of the normal modes, and can be written as 











ααα +kQ  Higher order terms                          ( 19 ) 
 
Here Qk represent the normal coordinate and α0 is a constant.  Then the 














ααμα                                                            ( 20 ) 
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The expression for µ becomes  
          [ ]ttQEtE k
k
k πνπνμ








+=                 ( 21 ) 
etric identity for the product of two cosines, equation 
1.9 can be rewritten as follows: 
Finally using the trigonom






∂0          ( 22 )ttQEtE kkk ννπννππναμ −++⎟
⎠
⎜+= 2cos2cos2cos 000  
Therefore, equation 22 shows that when a molecule vibrates with frequen






frequencies. The above three terms of equation 22 represent the three major 
phenomena observed in a Raman spectroscopy experiment. The first term in 
equation 22, the radiation scattered at the frequency ν0 ( the Rayleigh scatteri
and is a coherent type of scattering since it is in phase with the incident 
radiation. The second term of frequency ν+νk is anti-Stokes Raman scattering 
and the third term is Stokes Raman scattering (Fig. 1-2). For a transition 
observed, it is clear from equation 22 that those vibrations for which α’k=0 , ar
inactive in Raman scattering, and those normal vibrations for which at least one
















α ( 23 ) ⎟⎜ij                                                                                    
 
Raman scattering can be described both in terms of ‘classical theory’ and 
uantum theory’. The classical theory is based on the wave theory of light and 







haracterization of protein and protein-drug interaction using two completely 
) and  adapt the  high performance 
Raman ore waveguide 
d 5 
-ligand 
account for the presence of anharmonicity. Therefore, the better descriptio
anharmonicity is attained with the Morse potential ( Fig 1-2 ). A more thorough 
discussion  of quantum theory expression is beyond the scope of this thesis 
can be found elsewhere  57, 58. The inharmonicity further describes the 
vibrational modes of the overtones and combinations. 
 
1.4 Thesis Objectives and Overview 
The overall objective of this thesis was investig
c
different techniques ( CIEF and  spectroscopy
 spectrometer developed by P&P Optica® Inc. for liquid c
( LCW) experimental configuration .  Accordingly, chapters 2 and 3 focus on 
the development and application of high performance Raman spectrometer 
based on VPH (volume phase holographic) grating.  Chapter 2 discusses the 
novelty and the overall optical components configuration of the system and 
chapter 3 describes application of LCW- Raman spectroscopy (RS) and 
successful implementation of LCW cell for the Raman system. Chapters 4 an
describe the application and result of CIEF and CIEF with Fluorescence 
detection for the investigation and characterization of protein and protein
interaction. Finally, conclusions the future directions are drawn in chapter 7. 
The development and the applications of the two dimensional separation 
technique to determine the diffusion coefficient, molecular weight and pI  of 
polypeptide and protein  are discussed in Chapter 6. 
CHAPTER 2 
 
INEXPENSIVE AND HIGH PERFORMANCE RAMAN 
SPECTROMETRY USING VOLUME-PHASE 





  Raman spectrometry using a volume-phase holographic (VPH) 
diffraction grating is well suited for providing real-time quantitative analyses of 
chemical compositions in gas, liquid and solid mixtures, albeit usually with only 
modest sensitivity, limited by the low Raman scattering cross sections of most 
substances. The technique measures the vibrational frequencies of molecules as 
related to their molecular structures. Raman spectra provide both the unique 
fingerprints and quantitative information of the molecules present in a sample 
under examination. Laser Raman spectrometry is particularly advantageous for 
monitoring samples because of its excellent differentiation among species 
compared with techniques of comparable sensitivity such as mass spectrometry 
and gas chromatography. 
           This versatile technique has been frequently applied for the investigation 
of molecular species. When compared with conventional reagent-based analytical 
techniques, the Raman technique offers the advantages of speed and low operation 
cost over the long term. Thanks to advances in technology during recent years, 
primarily the fast development of a sensitive detector, notch filter, inexpensive 
lasers and new data analysis software, Raman spectroscopy has become widely 
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used in many scientific disciplines, especially in pharmaceutical, biological and 
chemical research. Over the past 10 years, Raman spectroscopy has gained 
increasing prominence as a quantitative tool for the analysis of biological samples. 
The technique is regularly used for identification, characterization and investigation 
of new chemical substances or pharmaceutically active compounds. Raman 
measurements of metabolites and therapeutic drugs were performed in solutions of 
water or single solvents. However, a few drawbacks make the conventional Raman 
systems impractical in clinical practice. For such analytes, the signal acquisition 
time must be longer since Raman scattering is a weak phenomenon. The other 
obstacle is the small concentration of desired analyte relative to the background 
spectra. Fluorescence in particular creates a problem, and thus, vigorous sample 
processing is required to remove the interferences. 
       Finally, for quantitative measurements, reproducible laser delivery is 
required for consistent data. Thus, the quest for building a simple, portable, high 
resolution, user-friendly configuration with broader applications and flexibility for 
other possible configurations has been a driving force in the development of a 
better Raman system.  
           In this chapter, we discuss the design and implementation of a new 
Raman system with a VPH grating-based Raman spectrometer, as a possible 
solution to overcome the aforementioned problems. The present technique 
differs from commercial Raman instruments, because it uses less expensive and 
high-quality optical components, and the system incorporates a more versatile 
optical design, in which the focus of the Raman excitation laser may be 
independently aligned to the reference window (integrated cell) and the sample. 
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The system ensures freedom from daily adjustment and alignment of the optical 
components. Moreover, this method requires no special sample preparation and 
is compatible with a high-speed analysis subtraction procedure, which may be 
conveniently used to both calibrate the sample and remove background peaks 
from the sample spectrum. Thus, this combination of hardware and software 
promises to be widely applicable in a variety of academic, industrial and 
chemical analysis applications. 
Finally, the research described here has been performed at the P&P 
Optica  Inc Laboratory. Several aspects of this study have been supported by 
collaboration with this company. The VPH grating-based Raman spectrometer 
has developed by P&P Optica Inc., which is based in Kitchener, Ontario, and 
the company is based around the technical expertise and experience of  
Dr. Pawluczyk. Dr. Pawluczyk   is a senior scientist and a pioneer with an 
extensive research and academic experience in the field of modern optics. He is 
the inventor of 30 high quality patents1-4  and the author of 90 scientific journal 
articles. Our group has been benefitted from the technology and expertise the 
company provides through our research collaboration. This collaboration 
represents a big step forward for our labs and lines up with our focus on 
continuous improvement of our spectroscopy division and positively impacts 
the effectiveness and quality of our research. 
P&P Optica Inc, develops customized spectrometers for a variety of 
applications, primarily compact and inexpensive instruments. This small 
company with an innovative work environment placed a strong emphasis on 
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working together and sharing ideas and knowledge. Exploring diverse areas as 
mathematical modeling of physical processes, signal and image processing. The 
company also provides consulting support, maintains facilities for customer support 
or local follow up as needed. 
2.2 Experimental 
 
2.2.1 Outline of the new instrument 
 
           A schematic of the high-performance Raman spectrometer is shown in 
Fig. 2-1. It was designed to measure Raman spectra and fluorescence emission. 
The diagram illustrates the schematic and key components of the Raman 
spectrometer system equipped with a VPH diffraction-grating combined with 
refractive optics. The system consists of three main parts: (1) the spectrometer, 
which includes the VPH grating, illumination optics and focusing optics, (2) 
laser filter and detector, (3) integrating cavity cell1 which is designed using 
Teflon to hold the sample. Each of the major components of a VPH-based 
Raman spectrometer shown in Fig. 2-1 is discussed separately in the following 
paragraphs, followed by a discussion of the application of the system. 
 
Figure 2-1. Schematic of VPH-based line imaging / multichannel spectrometer 3, 5, 6. 
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             In  simple design ( Fig.2-1), light from a continuous wave (CW) argon 
ion laser (λ = 488 nm, Cyonics) and a diode laser operating at 785 nm is 
directed at the sample holder (integrating cavity cell) using an optical fibre (0.2 
mm core diameter). Two optical fibres are used to direct and collect the laser 
radiation from the sample holder. The use of fibre optics for light transmission 
has several advantages. The excitation radiation can be efficiently coupled into 
a single fibre that will efficiently transport the photons to the. The Teflon-based 
integrating cavity cell is constructed in such a way that both fibres are 
connected to the same cell for the excitation and collection of photons that are 
scattered from the sample. The cell also allows Raman-scattered light from 
every position from the sample to enter the collecting optical fibre. Both ends of 
the fibres are connected to an FC/PC connecter to simplify the connections to 
the laser and to the sample holder. This also provides stability for the optical 
fibres from the mechanical movement of the sample holder. The fibres in the 
bundle are also arranged linearly at the entrance of the spectrograph, thereby 
allowing the Raman-scattered light to be focused on the slit. This is an 
important part of the instrumental configuration because the intensity of the 
scattered light is maintained. This may also be one of the major reasons for 
problems that create distortions in the spectra, thus resulting in poor 
reproducibility if configured improperly.  
  
        The refractive optics specifically designed to produce a straight image of 
the slit (10 µm) for each wavelength and straight spectral line for each point of 
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the slit .The scattered light then passes through an entrance slit and disperses on 
a collimating mirror. Each point at the entrance slit creates a separate spectrum, 
which registers on a separate row of a detector array. For instance, if multiple 
fibres are placed along the slit, the spectrometer provides a separate spectrum 
for each fibre. The collimated beam then strikes the VPH grating, which is close 
because of the collimating optics. The VPH grating is transmission based. For 
the collimating optics image, the input slit is positioned in such a way that 
monochromatic images of each point of the slit are produced with minimal 
aberrations at the detector end, allowing for high spatial and spectral resolution. 
In most CCD-based spectrometers, such a configuration is absent.  
 
 
Figure 2-2. The schematic diagram of Raman spectrometer system using VPH-
based grating.  
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          The excitation sources are a CW argon ion laser (λ = 488 nm, Cyonics) 
and a diode laser operating at 785 nm at 10-100 mW laser power. The laser 
intensity is adjusted depending on the power requirement. For data consistency, 
laser power is periodically measured at the sample using a LaserCheck 
(COHEREnT) pocket power meter.  
 
2.2.1.1 Volume phase holographic (VPH) diffraction grating 
  In the modern information age, it has become very important to acquire 
data rapidly, especially in the optical communication field, where high-speed 
spectral analysis is needed. New applications require that instruments are 
always increasing in efficiency, reduce size, bandwidth, wavefront and thermal 
behaviour. Usually, an optical dispersion system, such as a monochromator, is 
used in experiments. The optical dispersion element, a grating or prism, will be 
mechanically rotated continuously or in very fine steps to scan the wavelength 
and achieve high spectral resolution in the measurement. The production 
method of most gratings is either a process involving the mechanical scratching 
of the surface of a substrate or exposure of a photoresist layer deposited on a 
substrate (glass or Perspex), where the interference pattern produced by two 
coherent light beams is used to expose the photoresist. Depending on whether 
the light is reflected from the grooved surface or transmitted through it, the 
grating is called either a reflection or transmission diffraction grating. The 
diffraction efficiency or the percentage of light that is angularly separated by the 
grating partially depend not only by the spatial frequency, and the angle of 
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incidence of the incoming light and the optical properties of the grating 
material. In particular, the diffraction efficiency of reflecting relief gratings is 
determined by the shape of the grooves and the reflectivity of the grating. While 
efficiency of transmission grating also depend on the shape of the groves and 
refractive index of the material,  in both cases, the diffraction efficiency also 
depends strongly on the polarization of the incident light. Another alternative 
diffraction grating has recently become available through advances in 
holographic technology. These gratings, called VPH, show superior 






Figure 2-3. Illustration of  physical structures of different 5 ( Reprinted courtesy 
of P&P Optica Inc) gratings. 
 
A VPH works on a different principle. It involves a sensitive layer 
(dichromated gelatin, silver halide sensitized gelatin or photopolymer) deposited 
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on a substrate. The output from a laser source splits into two beams, which cross 
each other inside the photosensitive media (volume), thus creating an 
interference pattern in the space shared by both beams. The film then responds 
to the exposure by a change in the area where the interference is constructive. 
Then this change in density causes the gel to undergo a slight modulation of its 
refractive indices. The exposed film goes through a chemical process 
(depending on the nature of the sensitive layer)  to amplify this refractive index 
modulation. In such a way photosensitive layer exposed to a periodical 
modulated light intensity becomes a diffraction active structure with 
periodically modulated refractive index when such a layer exposed to light 
beam and it acts as diffraction grating separating spectral components of 
different wavelengths. Usually, the optical layer of a VPH is encapsulated with 
a hard transparent cover to protect it from environmental damage. 
VPH gratings potentially have many advantages over classic surface-
relief gratings. The major advantage of VPH over the classic type is the 
tunability nature, which allows more versatility with a single dispersive element 
than achieved with  classical gratings, 5 resulting in the desired wavelength 
being observed with the desired dispersion. Additionally, VPH grating 
structures can be stacked to produce complex gratings capable of directing the 
diffracted light in ways that classical gratings cannot. Performance parameters 
include diffraction efficiency, spectral coverage and angular coverage, etc. 





Figure 2-4. Configuration of an assembled VPH grating. 
 
Table 2-1. Comparison of VPH and standard relief gratings (HRR) 5  
 
Performance Tested Parameter 
HRR VPH 
Efficiency, narrow band (tens 
of nm) 
~ 90% Close to 100% 
Average efficiency, (one 
octave) 
20% - 30% > 60% 
Band and efficiency product Hardly controlled Well controlled 
Efficiency, as a f(dispersion) Decreasing Increasing 
Polarization dependency Strong Weak 
Efficiency curve f(wavelength) Irregular curve Regular 
Scattered light At detectable limit Below detectable 
limit 
Focusing ability (no additional 
optics) 
Over the entire spectral 
range 
Limited capabilities 
Imaging quality, focusing 
grating 
Strongly astigmatic Astigmatic 
Imaging quality, plane grating Diffraction limited Diffraction limited 
Work in high dispersion 
Littrow configuration without 
additional optics 
Possible in whole 
spectral range 
In limited part of 
visible and short 
NIR range 
Work in high dispersion 
Littrow configuration with 
additional optics 
Limited efficiency in 
whole spectral range 
Highly efficient in 
whole spectral range




Stacking of multiplicity of 
elements 
Impossible Possible 
Surface protection Impossible Can be fully 
protected 
Temperature range Standard Up to above 100°C 
Humidity Non-condensing Boiling water (with 
surface protection) 
Power resistant Limited High, depends on 
spectral range 
Production technology Mature, well 
established 
Limited number of 
experienced 
companies 
Pricing Established price Higher, low volume 
production 
Price of imaging gratings High Competitive 
Price of plane gratings 
(replica) 
Low Higher (if protected)
 
 
The experimental set up is shown in Fig 2.2. The excitation source is 
600 mW semi-conductor diode (785nm) CW lasers. The laser beam is coupled 
with an optical fibre coupler on one side of the Teflon tube. The scattered 
photon flux is collected and collimated by three different mirrors and directed to 
the VPH. The focusing optics located before the detector focus the scattered 
photons on the detector. The detector (Princeton) is described below. The 
instrument was designed by P&P Optica Inc.5  
2.2.1.2 Detector 
  The light spatially dispersed by grating, and collected by focusing optics 
and recorded on CCD (Princeton Instrument/Acton, Model PIXIS 256). The 
CCD is cooled thermoelectrically down to -750C to provide the lowest dark 
current (~0.006 e-pixel sec-1). This high-performance detector provides excellent 
response from UV to NIR. The back-illuminated and deep depletion with anti-
etaloning technology gives the detector additional sensitivity in the near IR 
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region while the special coating for UV allows use in the deep UV region (Fig 
2-5). In an imaging array with 1024 x 256 pixels, each pixel has a dimension of 
26 µm x 26 µm. 
         A collection time of 10 to 20 s with a laser power of 150 mW or 200 mW 
at the sample are used in all Raman measurements. Standard computer software 
(Winspec, Princeton Instruments, Inc.) is used for data acquisition and Octave 
(a free open source software) is used for spectral subtraction and normalization.8 
Raman frequency shifts are calibrated using a cubic polynomial fit to neon 
emission lines.  
 
Figure 2-5. Quantum efficiency curve of a deep depleted CCD detector. 








2.2.1.3 System Calibration 
When using an excitation laser with a fixed frequency, such as the 785 
nm laser used in this work, it is more convenient to use a standard emission 
source such as a neon lamp, which has numerous sharp lines of known 
wavelength in the Raman Stock shifted spectral region. We have fit several such 
atomic transitions lines to a Gaussian peak shape in order to accurately 
determine the peak position of each line with a resolution of better than one 
CCD pixel. The resulting values of pixel peak position are plotted against the 
known wavelengths of each neon line and fit to a cubic polynomial in order to 
determine the pixel-to-wavelength calibration function. The Raman shift 
frequency at each CCD pixel is obtained by converting the wavelengths 
corresponding to each pixel to frequencies and then subtracting the frequency of 
the narrow spectral band semi-conductor (12,738.85 cm-1) laser. 
 
2.2.1.4 Laser line and edge pass filters 
        The laser radiation is directed toward the slit by the use of a Laser line 
Filter (Raman filter 785 nm, Iridian Spectral Technology Ltd., Ottawa, Canada). 
This filter performs two functions: First, it narrow emission band of Raman 
excited laser line and cleans up the beam by blocking wavelengths, which are at 
fluorescence wavelengths. Secondly, this filter also provides further filtering of 
ambient and plasma light. The instrument also equipped with a long pass band 
filter (edge pass filter) which provide a sharp cut-off either above or below of 
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785 nm laser line. This filter is useful to isolate specific regions of the spectrum. 
The transmission wavelengths (794.5-1200nm) is 90%. 
2.2.1.5 Integrating cavity cell 
     Because the Raman signal is scattered in all directions, for weak scattering 
one needs to use a sample holder that can minimize photon loss. For these 
reasons, special cylindrical-shaped sample holders made from a Teflon material 
were built. 
2.2.1.6 Data collection 
        Tylenol spectra were collected using a 100-200 mW solid-state excitation 
laser with 10 to 20 sec integration time.  
2.2.1.7 Data processing 
        First, high quality Raman spectra are collected before and after placing the 
sample into the integrating cavity cell. The spectrum obtained with an empty 
Teflon tube represents the Teflon reference spectrum. The spectrum obtained 
from the filled tube and the cell contains both sample and Teflon spectral 
features. The Octave software is subsequently used to subtract the Teflon 
reference spectrum from the mixed spectrum. After Teflon subtraction, the 
sample spectral intensity is normalized by dividing the sample spectrum by an 
appropriate coefficient, which represents the Teflon window intensity. Thus, the 
resulting sample spectrum contains no Teflon spectral features and is 
normalized to correct for any changes in either laser intensity or collection 
efficiency of the Raman spectrometer. 
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       In addition, a measurement was made on the CCD full pixels at room 
temperature to monitor the readout noise from the CCD. Indeed, a dark noise 
collected without light displayed fluctuations in the baseline signal. This noise 
is very common in scientific instruments and increases as the exposure time is 
longer. During the data processing, the noise spectra from the CCD were 
subtracted and corrected from the collected spectra of the analytes.  
2.2.2 Materials and Chemicals  
 
         Commercial acetaminophen-based tablets were purchased from different 
drug stores. Tylenol, Pharmasave, Rexall, Compliments, Life Brand and Exact 
regular strength tablets (manufactured by McNeil consumer healthcare) were 
purchased from Shoppers Drug Mart Inc. All the samples were used without 
further treatment. 
2.2.3 Sample preparation 
          Tablets containing acetaminophen (Tylenol, Pharmasave, Rexall, 
Compliments, Life Brand and Exact regular strength) were prepared using a 
direct blend technique. The target tablet mass was 0.36 g. The coating of some 
of the tablets was systematically removed using a surgical blade. The samples 
mass, manufacturer, chemical composition and content of acetaminophen are 
given in Table 2-3. All samples were used without further treatment except that 
the coating of some of the tablets was removed to minimize the complexity of 




2.2.4 Theoretical calculation 
 
Theoretical calculations were performed using density functional theory 
( DFT) of Becke’s three-parameter functional including the correlations 
functional of Lee, Yang, and Parr (B3LYP)8  with Lanl2dz  basis set, to help the 
assignment of the Raman spectral peaks of acetaminophen. DFT theory 
describes a class of methods in which exchange and correlation contributions 
have been formulated based on solution of the Schrodnger Equaation for a free-
electron gas. The predicted wavenumber values have to be scaled with a general 
scaling factor (0.96)9 to adjust observed experimental wavenumber values. It 
was found that the calculated Raman vibrational wavenumbers are in good 
agreement with experimental values. The calculations were carried out using 
Gaussian 0310 software for Windows. 
 
2.3 Results and Discussion 
 
The application of a high performance Raman spectrometer has been 
adapted for measuring spectra in the UV, visible and NIR spectral ranges with 
the implementation of appropriate filters. This spectrometer was demonstrated 
to have superior stability, simplicity, accuracy, large throughput capacity, cost 
efficiency and sensitivity comparable to that of a multichannel dispersive 
commercial Raman spectrometer. Such an imaging system was initially 
intended to monitor multispectral fluorescence imaging. The laser, filter, laser-
focusing lens, VPH grating and detector were initially assembled and aligned to 
achieve a Raman signal from different Tylenol-based powders. Alignment and 
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control procedures have been developed to achieve an enhancement of Raman 
scattering light. 
         To test the ability of the Raman system, Tylenol tablets were used as a 
model compound. The detectability of a trace component in different 
acetaminophen-based Tylenol brands by Raman spectrometry is governed by 
the Raman-scattering signal from these components which are almost identical 
in chemical composition and which have observed with the same Raman 
spectral fingerprints. Table 2-3 shows the chemical composition of the 
acetaminophen-containing tablets used in this experiment. Acetaminophen has a 
chemical formula C8H9NO2. These tablets were manufactured by a different 
pharmaceutical company. Visual examination of the spectra collected from all 
seven samples show similar fingerprints, while  minor spectral differences are 
observed upon closer examination. By analyzing the spectra of all six samples 
and comparing with the regular Tylenol, it appears that there is a slight 











Figure 2-6. The calculated density functional theory ( DFT ) Raman intensities 
of Tylenol regular strength and molecular structure. 
 
          All of the spectra contain features associated with the solid mixture as 
well as the spectrum of the integrating cell (Teflon) as shown in Fig 2-9. The 
Teflon cell spectra were subtracted from that of the Tylenol powder spectra 
using a software subtraction. Only the spectral region between 250 cm−1 and 
2000 cm−1 was used in implementing the subtraction, as this region contained 
the major Teflon peaks. Note that there is not much overlap between the Teflon 
and Tylenol peaks, and so it was very easy to subtract the two spectra 
accurately. Normalization was performed using the Teflon peak at  
724.76 cm−1.Even if the Teflon spectra were very intense; the Tylenol peaks 
were clearly observable in spite of underlying broad Teflon bands.  
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Figure 2-7. Raman spectrum of Tylenol regular strength tablet in the 200 to 
2000 cm-1 spectral region. The excitation laser line is 785 nm. 
 
Table 2-2 Predicted frequencies and Raman intensities associated with the 
stretching modes of the OH, NH, and CO chemical functions and the CH 
stretching modes of the CH3 group and the phenol ring of acetaminophen in the 




















66.1878 3.0426  Ring deformation 
132.0998 12.5642  Ring deformation 
179.7619 6.9586   
277.5637 7.7 
 Ring def, ring CH 
wagging 





416.39 18.5396 392 Ring def 
421.2618 2.2959  Ring def 
433.1068 8.8299 464 Ring def 
450.4276 8.9355 502 Ring dis 
545.8999 33.6041  Ring dis 
645.9714 75.743 
625 Ring def,N-H 
bending 
653.4761 1.8247 651 Ring dis 
706.9466 6.047 709 Ring def 
825.9316 34.205 796 Ring dis 
831.9097 52.7648 
832 Ring def,ring C-H 
bending 
861.3466 2.5734 855 Ring dis 
888.345 65.6365  Ring C-H bending 
958.2629 2.1014 
967 Ring C-H 
antisymmetric str 
994.1738 0.2204   
1028.687 1.6904 1016 Ring dis 
1030.443 3.2572 
1104 Ring C-H 
antisymmetric str 
1134.856 66.9448 1168 Ring breathing 
1267.208 60.3871 
1258 Ring C-H in phase 
symmetric streching
1290.498 3.0471 
1279 Ring breathing,N-H 
bending 
1353.311 24.2986 




1372 Ring def, O-H 
bending streching 
1425.583 16.646 
1429 Ring def, C=O 
bending 
1456.476 137.979  Ring C-H wag 
1535.364 0.6595   
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1560.913 70.1245 1562 Ring def 
1643.504 31.3323 




1650 Ring def, N-H 
bending, ring C-H 
bending 
1683.072 63.8111   
    
• Def= deformation      dis=distortion 
• str= stretching 
• Wag=wagging 
 
         The Raman spectrum of acetaminophen-based Tylenol regular is 
illustrated in Fig 2-7, which shows several bands. An examination of the Raman 
spectra which excitation laser 785 nm (Figure 2-7) shows a typical Raman 
spectrum of acetaminophen-based Tylenol tablets. Thus, all of the spectra 
contain features associated with acetaminophen. Note that the chemical 
compositions of these tablets are based on this compound and some added 
additives such as a narcotic. Depending on the brand of a particular tablet, the 
concentrations of these additives varied from brand to brand. The detailed 
assignment of all these bands of Tylenol has been made on the basis of the 
theoretical prediction of acetaminophen (Table 2-2). The assignments of the 






























































starch, corn starch, 
stearic acid, 
providone 
Pharmetics Inc. 0.3633 
 
          In the Raman spectrum of acetaminophen, the band which appear at 1649 
cm-1 is due to the C=O stretching vibrational modes. The band -NH deformation 
mode occurs near 1612 cm-1 , and HN-C=O bend  at 1562 cm-1. The band 
observed at 799 cm-1 is attributed to the phenyl ring-stretching mode. Other 
Raman vibrational modes between 1350 to 1180 cm-1 region are due to N-H 
bending and C-H deformation vibrational modes. All the observed vibrational 
bands are in close agreement with the reported literature11. However, clear 
assignments for the other bands are presently uncertain. 
The detection capability of our system was determined not only by 
measuring the Raman spectrum of a single tablet (Tylenol regular), shown in 
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Fig. 2-8, but also by collecting Raman spectra from two Tylenol tablets from 
different brands. Since the concentration of acetaminophen is very high in all 
the tablets, the overall spectral features are dominated by this compound. The 
Raman spectra measured at room temperature reveal several peaks 
corresponding to acetaminophen. These spectra underlines the major peaks that 
are typical Raman vibrational modes of Tylenol. 
  Raman spectra of the Life Brand and Tylenol regular strength tablets 
were collected and compared. Fig. 2-7 shows the resulting spectrum 
containing the typical acetaminophen features. The intense background in the 
ranges 400 to 1000 cm-1 is from the Teflon background. Two different 
spectral ranges of 400 to 800 cm-1 and 1100 to 1500 cm-1 are used to evaluate 
the spectral features of the two tablets. There are two bands absent for the Life 
Brand tablet at 1143 and 1427 cm-1  but they appear in the Tylenol regular 
strength tablet, demonstrating a minor difference between the two tablets. The 
other striking observation is the higher intensity observed for the Tylenol 
regular strength compared to the Life Brand. Note that the observed Raman 
intensities of the two peaks are very weak, which may give insight into the 
chemical compositions of the two tablets. In addition, three more peaks at 
410, 510 and 1400 cm-1 were observed for Life Brand but not for other 
sample. These results support the high performance sensitivity of the Raman 
system. 
  By the same argument, all seven spectra are superimposed and 
illustrated in Fig 2-9. The Raman features of acetaminophen appear dominant 
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due to its high concentration in all tablets. Note that the baseline of each 
spectrum shown in Fig. 2-9 is filtered to a third order polynomial and the 
resulting baseline model is subtracted from the spectrum to generate the 
baseline-corrected spectrum. As mentioned earlier, closer examination of the 
seven spectra reveal a minor difference in intensity, peak area and position 
observed on the shoulder of the intense peaks near 400, 600 and 800 cm-1 
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Figure 2-9. Raman spectra of seven acetaminophen-containing Tylenol tablets. 
; curves (1-7), Tylenol regular strength, Pharmasave, Rexall, compliment, Life 


















 High performance Raman spectrometry has been adapted for measuring 
spectra in visible and NIR spectral ranges. This spectrometer was demonstrated 
to have superior stability, simplicity, wavenumber accuracy, large throughput, 
cost efficiency and sensitivity comparable to that of a multichannel dispersive 
Raman spectrometer. The laser, filter, laser-focusing lens, VPH grating and 
detector were assembled and aligned to achieve a Raman signal from different 
acetaminophen-based powders. Alignment and control procedures have been 
developed to achieve an enhancement of Raman scattering light. 
        The performance evaluation measurement was performed using Tylenol 
tablets with minor differences. Thus, this new Raman spectrometer certainly 
provides various physicochemical properties, which are not obtainable with a 
commercially available Raman spectrometer. This advantage can be extended to 
other heterogeneous samples, such as pharmaceuticals or biological samples. 
However, much work remains to be done before this system can be used for 
very low analyte concentrations. Thus, in the future, it would be beneficial to 
perform more experiments in order to gain a better understanding of the system 
and to improve it. Finally, the results of this study demonstrate the promising 
future for coupling the Raman system to capillary isoelectric focusing (CIEF) 








APPLICATIONS OF  HIGH PERFORMANCE LIQUID-
CORE WAVEGUIDE  RAMAN SPECTROSCOPY  
3.1 Introduction 
Since the discovery of light guiding in liquids by Colladon 1, Babinet2, 
and Tyndall3 in the mid 19th century, the phenomenon of liquid-core guiding has 
attracted attention both in and outside the scientific community. By end of the  
20th century, this effect  was widely known due to its usage in illuminating 
fountains4. Since then a number of liquid-core fibers, consisting of small 
diameter glass tubes, were developed with  high refractive index solvents. These 
liquid-core fibers performed well with  minimum radiation loss ( 8dB/km) when 
near infrared radiation was used5.  
 
  A liquid-core waveguide (LCW) can be made from an optical grade 
tubing material, in which the wall of the material has a lower refractive index 
than the liquid-core material. Under this physical condition, it is possible for 
light to propagate down into the core of the waveguide and be guided over a 
significant length. To achieve this effect, light goes through a total internal 
reflection (TIR) at the interface between the wave guide tubing walls and the 
sample which flows through the hollow core of the Teflon tube. Such a situation 
is achieved if the light carrying liquid core is bounded by optically transparent 
walls that are made of a material with a refractive index (RI) less than that of 
the liquid of interest.  This phenomenon can be explained using Snell’s law: 
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        n1sinΘ1=n2sinΘ2                                                                               (1) 
        sin-1(nclad/ncore)=Θcritical    or sin Θcritica =  nclad/ncore                                  (2) 
 
where n2 is the index of the cladding material and n1 is the index of the fluid-
core. According to the above equation, light travelling through the liquid core at 
an angle less than Θcritical will be trapped in the core resulting in TIR. However, 
light travelling through the  core at higher angles than Θcritical can travel into the 
cladding and in the core. Furthermore, the propagated light will exit the fiber, if 
n > ncritical  and  the angle of refraction of light is greater than Θcritical  ( Fig3-1). 
For Teflon AF 2400 (n=1.29) and water (n=1.33), Θc is 14.1°. 
 
 
Figure 3-1.  Schematics of liquid core optical fibre. The waveguide extends the 
laser light path length through total internal reflection inside the Teflon tubing. 
 
     Most waveguide spectroscopy is performed using plastic capillaries. In 
addition to  their excellent performance, they are extremely flexible and 
breakage resistant and contain light entirely within the core liquid. Within the 
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last six years, several    liquid core waveguides  for use with water have been 
fabricated  from amorphous copolymers such as fluoropolymers 2,2-
bis(trifluoromethyl)-4,5-difluoro-1,3-dioxole6 and polytetrafluoroethylene ( 
PTFE) and are now commercially available. This later polymer is called by its 
trade name Teflon AF and has been used as an aqueous-core optical waveguide 
for signal enhancement due to its low refractive index (RI ) (1.29-1.31)7, which 
is slightly lower than that of water (1.33). In recent years, Teflon AF has 
become a leading polymer with nd lower than most known materials, which 
facilitates waveguiding through aqueous media at standard temperature and 
pressure.  The number 2400 refers to the glass transition temperature (Tg) in 
degrees Celsius. The Tg of AF is 2400C and it has nd=1.29. Teflon® AF  not 
only posseses the above listed properties, it is also  physically  and optically 
stable and transparent (> 96% transmission )in the spectral range from 200 to 
2000 nm8 .  In addition, Teflon AF is chemically resistive and very flexible, so 
that it can be readily coiled for applications that demand long path lengths.    
 
  Teflon-AF 2400  based systems have been  widely used  for absorbance 
spectroscopy 9, fluorescence10, 11, liquid chromatography 12, gas chromatography 
13, Raman spectroscopy in long fibers14-16 and capillary electrophoresis 17.  
Signals such as Raman or fluorescence are enhanced by LCW due to the ability 
to excite a greater number of molecules along the path of the laser. Depending 
on the length of tube and specific application, signals can be collected from the 
entire volume of the wave guiding region. The main advantages using LCW 
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with Teflon AF are that high spontaneous Raman intensities can be obtained 
from a long path with minimum radiation loss from a small volume of sample, 
and the system does not require complicated optical configurations. In addition, 
the use of small samples is particularly important for valuable samples in areas 
such as medical, forensic, biological, and environmental analysis. 
 
  The first Raman application using LCW based on Teflon AF 2400 was 
reported by Altkorn et al. 14, 15. However, prior to Altkorn’s work, Walrafen and 
Stone used long path liquid core waveguide cells made of PTFE (silicon tube)  
to characterize benzene and tetrachloroethylene 18, 19. The spectra collected from 
the two analytes were of good quality with low noise. Some extra features 
appeared which had never  been observed before. Furthermore, Walrafen and 
Stone reported an intensification factor of 3000 for benzene in a 15-m fiber, 
while the intensification factor for tetrachloroethylene performed in a 25-m 
fiber was 300.    Even though excellent enhancement and reproducible data 
were observed for the above techniques, the system was not immune to a loss of 
radiation 20.  These losses were observed because of the extraordinary care the 
PTFE required when used as a cell for LCW at a later time, Schwab and 
McCreety performed a similar experiment as Walrafen using a thin-wall glass 
tube as LCW, attached to a remote spectrometer through a fiber bundle 21. In 
this system, they used one fiber brought to the excitation source and 18 parallel 
fibers for Raman scattering collection.  However, more recently, a simple 
inexpensive Raman spectrometry was used with a simple configuration of two 
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fibers ( one transmitter, one receiver)22.  In this configuration, a CCD detector 
and a diode laser were used for detection and excitation of samples from LCW.  
 
  As already mentioned in the previous paragraph, the major advance in 
LCW-based spectroscopy of aqueous solutions was the introduction of a new 
amorphous fluoropolymer, Teflon AF. The commercial availability of tubing 
manufactured from Teflon AF led to a surge in the development of LCW.  LCW 
cells have contributed greatly to enhancing Raman signals as well as several 
other applications. Raman signals can be observed from liquids forming the 
high-index core of a light guiding system. If a laser beam is propagating down a 
liquid core fiber, all the Raman photons emitted into a certain solid angle will be 
similarly propagated. However, photons emitted by impurities also propagate 
down the fiber and contribute to the overall collected signals. In principle, it is 
possible to overcome such extraneous signals by using good data processing 
software. When light propagates through the LCW fiber, some light is scattered 
outside the TIR acceptance angle, and so it does not reach the detector. The 
light scattered within the capillary TIR and guided within the capillary 
significantly contributes to the Raman signal.  
 
     Raman spectroscopy has been employed extensively to study the 
conformation of the disulphide bridge in proteins and peptides, because the 
frequency of the S-S stretching mode of the S-S bridge is sensitive to its 
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conformations 23. These disulphide pairs are located between helical segments 
of domains. 
 
  The investigation of the disulphide bridges of human serum albumin       
( HSA ) is our principal target, because the S-S stretching modes are very 
sensitive to the conformational change of HSA. X-ray crystallographic studies 
of HSA confirm that all the disulphide bonds are gauche-gauche-gauche (ggg) 
conformation. 24 However, other conformers were reported for bovine serum 
albumin (BSA) such as ggg (SS stretching band at 505 cm-1) and gauche-
gauche-trans (ggt) 520 cm-125. In this study, a strong Raman band at 492-431 
cm-1,assigned to ggg geometry, predominated in the Cys-SS-Cys residues, while 
weaker features at 454, 507 and 518cm-1 indicate other conformations of the 
CCSSCC chains, respectively having tgt and ggt geometry.  
 
  In the present study, the structural change of HSA in solutions has been 
investigated by LCW-Raman spectroscopy in order to explore whether the 
interaction of HSA with oxaliplatin is responsible for the breakage of the S-S 









  3.2.1 Apparatus 
 
    3.2.1.1 Raman Instrumentation 
 
3.2.1.1.1 Raman Spectroscopy using 632.8nm excitation 
 
         Raman spectra were recorded on a Dilor-Jobin Yvon-Spex HR 800 Raman 
spectrometer, equipped with an Olympus BX 40 system microscope with 10, 50 
and 100x objectives (Fig.3-2). A He–Ne laser system with excitation line at 
632.8 nm and an excitation power of 10-20mW was used in the measurements. 
Spectra shown below are the accumulated averages of 10–15 exposures of  
5-10 seconds each at room temperature 21–23 °C. Average spectra were 
smoothed by a 5 cm-1 filter and were corrected by a polynomial baseline using 
LabSpec (Dilor-Jobin Yvon-Spex, France) software. The second derivative 
analysis of Raman spectra was made using Origin 8.0 software (Microcal 
Origin, USA). The obtained second derivatives of the spectra were applied to 
detect the positions of overlapping bands. Some spectral regions were analysed 
by the normalised least-squares curve-fitting procedure (PeakFit module of 
Origin 8.0) using multiple Voigt (Gaussian-Lorentzian mix) curves. 
 
3.2.1.1.2   LCW sample delivery        
A small amount of sample was transferred into a capillary tube, which was 
placed on the stage of the microscope. With the help of an internal light, it was 
possible to focus the microscope on the liquid in the centre of the capillary. To 
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acquire a spectrum, the internal light, and all other ambient light, was shut off, 
and laser light was then allowed to strike the sample.  
 
 
Figure 3-2. Schematic diagram of Raman system equipped with 632nm 
excitation line. 
 
3.2.1.1.3 LCW-RS system from a distance of 70 cm   
 
Two different instrumental configurations were designed and are shown 
in Fig.3-3 and 3-4. Both figures illustrate the schematic and key components of 
the LCW-RS system. The system consists of three main parts, namely, the 
spectrometer which includes the volume-phase holographic (VPH), 
transmission lenses, laser filter and detector, LCW cartridge, which is designed 
using Teflon AF ( 150 µm inside diameter (i.d.) x 360 µm outside diameter 
(o.d.) tube, and the optical fiber coupler containing the laser filter  and the two 
laser sources. In the first configuration, a single mode polarization-maintaining 
optical fiber that was suited for λ=785 nm was polished and directly inserted 
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into the Teflon tube. A laser beam, from a continuous wave (CW) Argon ion 
laser (λ=488 nm, Cyonics) was launched into the free-space fiber coupler 
(KT110), which is equipped with a focusing aspheric lens (C230TM), a laser 
line filter and iris diaphragm. The beam from the laser is sent through a 
narrowband interference filter which cleans up the beam by blocking emission 
line of laser plasma tubes.  The aspheric lens is selected so that it gives the best 
result for visible and near IR lasers that have beam diameters around 1 mm.  
The iris diaphragm is used on the input end of the coupler to ensure laser beam 
transmission through the optical fiber. By adjustment of the iris, the laser beam 
can be centered on the aperture of the FC/PC (fibre channel/physical contact) 
receptacle. Since the fiber coupler has an optical axis that is 3.7”, the height of 
the laser beam was setup from 3.5” to 3.9” above the surface of the optical 
table. Note that only one end of the optical fiber is connected to the FC/PC 
connector to simplify the connections to the laser.  This coupler is equipped 
with an XYZ translator which is movable and threaded at the center section of 
the device. The XYZ translator which hold the LCW cartridge, align the fibre 
optic coupler in three dimensions to fit the laser beam in such a way to obtain an 
optimum coupling.  
 
     The laser beam guided by the optical fiber is injected into the Teflon AF tube 
coupled with the optical fiber coupler to illuminate the Teflon AF (50 mm) 
cartridge that is mounted on the XYZ translational stage.  The schematic 
description of the sample cartridge can be found in section 3.2.5 of this chapter. 
However, for this configuration, the sample was placed 80 cm from the entrance 
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slit of the spectrometer.  For Raman signal collection, the entrance of the 
spectrometer is equipped with a lens with focal length of 105 mm. 
For the second instrumental configuration (Fig. 3-4), a short Teflon tube 
as the LCW was attached to a simple two-fiber (one transmitter, one receiver) 
for Raman signal collection.  The attached optical fiber was connected to a 
FC/PC connecter and transmitted the scattered signal from a small area from the 
Teflon tube to the entrance of the spectrometer.   
3.2.2 Data collection 
Spectra are recorded with a Princeton Instrument/Acton Model Pixis 256 
camera (1024 x 256 array) a collection time of 10- 20 s with a laser power of 10 
to 20 mW at the sample are used in all Raman measurements. Standard 
computer software  (Winspec, Princeton Instruments, Inc.) is used for data 
acquisition, and Octave ( a free open source software) is used for spectral 
subtraction and normalization.8 Raman frequency shifts are calibrated using a 
cubic polynomial fit to Ar-Hg emission lines.  
 3.2.3 System Calibration 
     When using an excitation laser with a fixed frequency, such as the 785 nm 
laser used in this work, it is more convenient to use a standard emission source 
such as an Ar-Hg, which has numerous sharp lines of known wavelength in the 
Raman shift spectral region. We have fitted several such atomic transitions lines 
to a Gaussian peak shape in order to accurately determine the peak position of 
each line, with a resolution of better than one CCD pixel. The resulting values 
of pixel peak position are plotted against the known wavelengths of each neon 
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line and fit to a cubic polynomial in order to determine the pixel-to-wavelength 
calibration function. The Raman shift frequency at each CCD pixel is obtained 
by converting the wavelengths corresponding to each pixel to wavenumbers and 
then subtracting the wavenumber of the He–Ne laser line 632.8 nm  
(15, 802 cm-1), Argon ion, 488 nm (20,491.80 cm–1) and diode, 785 nm 
(12738.85 cm–1) laser lines. 
3.2.4 Raman Signals 
    For the measurement of each sample, the power of the laser remained at 10-
20 mW. It was found that the 1-10 sec acquisition time was adequate to record 
the spectral data with acceptable signal to noise ratios (SNRs), compared with 
the few minutes of acquisition time required by other Raman systems. 
3.2.5 Data processing 
     First, high quality Raman spectra are collected before and after placing the 
solution of interest in the sample cell. The spectrum obtained with an empty 
Teflon tube represents the Teflon reference spectrum. The spectrum obtained 
from the sample filled tube contains both sample and Teflon spectral features. 
The Octave software is subsequently used to subtract the Teflon reference 
spectrum from the mixture spectrum. After Teflon subtraction, the sample 
spectral intensity is normalized by dividing the sample spectrum by an 
appropriate coefficient which represents the Teflon window intensity. Thus, the 
resulting sample spectrum contains no Teflon spectral features and is 
normalized to correct for any changes in either laser intensity or collection 
efficiency of the Raman spectrometer. 
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Figure 3-3. Schematic diagram of Raman spectrometer showing the fibre 







Figure 3-4.  Schematic drawing for apparatus for the measurement of Raman 




3.2.6 Raman Liquid Waveguide Assembly 
 
The schematic diagram of the cartridge that we have developed for 
characterization of protein-drug interaction is shown in Fig 3-5. An important 
aspect of this cell is the Teflon AF tube, which was based on the previous 
design in our laboratory.  A Teflon® AF 2400 (150 µm i.d. x 360µm o.d., ~ 5 
cm) long was cemented on a glass slide.    In order to effectively focus the 
excitation laser into the Teflon waveguide, the Teflon tube was sandwiched 
between two glass sheets which is 2 mm thick and 7 cm long.  The distance 
between the edge of the two glasses to the tube remained the same.  The issue of 
stability and alignment of the sample holder (cartridge) is very crucial, as the 
Teflon tube is imaged on the slit of the spectrometer which is 50 µm compared 
with the inner diameter of the Teflon tube which is 150 µm. A spectral 
resolution of 2 pixels was achieved by setting the entrance slits to 25 µm. The 
LCW end cell was placed approximately 70 cm from the spectrometer entrance 
slit.  Light emitted from the LCW cell ( Fig. 3-4)  was imaged onto the entrance 
slit of the spectrometer with the use of an Nikkor  camera lens  ( f=105mm) 
centered approximately 70 cm from the end cell, which produced in image 
magnification of  0.125 at the slit entrance. In order to obtain the maximum 
Raman intensity, the assembled cell was moved back and forth, in order to 
image the LCW on the slit effectively. 
 
Therefore, to achieve the maximum detection of the Raman scattering of 
the sample, the sample holder and the spectrometer slit must be perfectly 
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aligned. A minor misalignment of the tube can make the data collection very 
time consuming and create spectral distortion.    This cartridge is mounted on 
the XYZ   stage with the option of moving it in three directions. Liquid samples 
were injected through the distal end of the tube using a syringe. Argon laser was 
injected into Teflon tube at the other end of the tube with a Ar+ ion laser 
operating at 20 mW or 785 nm diode laser operating at an average power of 20-
30 mW at the sample. We use a syringe pump ( Razel Pump Scientific) fitted 
with a Teflon tube to pump the sample into the liquid-core fiber , and we 
maintained the flow throughout the experiment. In this way, no void or bubbles 






Figure 3-5. Schematic and image of the liquid-core waveguide system from a 
distance of 70 cm using 785 nm laser line. LCW, AF-2400 tubing (i.d., 150 µm; 
o.d., 360 µm, length, 5 cm). 
 
3.2.6.1 Cartridge assembly for fluorescence measurement 
The anodic end was connected by glue with a piece of Teflon AF 2400 
capillary and the cathodic end was connected by glue with a piece of fused-
silica capillary, through two small pieces of microporous hollow fiber with a 30 
nm pore size, 380 µm i.d., and 440 µm o.d. (Hoechst Celanese, Charlotte, NC, 
USA). Two polystyrene vials were glued on the ends of the separation capillary 
as electrolyte reservoirs, and the effective detection length of the capillary was 5 
or 7.8 cm. The microporous hollow fibers functioned as physical barriers to 
prevent the macromolecule analyte from entering the electrolyte reservoirs but 
to allow small ions, such as protons and hydroxyl ions, to enter the separation 
capillary from the electrolyte reservoirs. A microtee (Upchurch ScientiWc, Oak 
Harbor, WA, USA) was used to couple the optical fiber into the cartridge from 
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the anode side and to introduce sample or solutions into the separation channel. 
The cartridge was mounted onto an x–y translational stage to facilitate 
adjustment of the cartridge to keep the separation capillary horizontal and 
parallel to the slit of the spectrometer. High voltage was provided with a RE-
3002B regulated high-voltage supply (Northeast ScientiWc, Cambridge, MA, 
USA). 
3.2.7 Materials and Chemicals 
 
     Teflon® AF 2400 tubing (150 µm i.d. x 360 µm o.d.) was purchased from 
DuPont. R-phycoerythrin (RPE) was purchased from Calbiochem–
Novabiochem (La Jolla, CA, USA), at a concentration of 20 mg/mL. Oxaliplatin 
(99.9%), ethanol, 1-propanol, 1-butanol, 2- pentanol, 1- hexanol ,  cyclohexane 
( >99%), FITC-labeled human serum albumin (FITC-HSA) and  human serum 
albumin (HSA, 70024-90-7, 98% purity, essential fatty acid free) were 
purchased from Sigma Chemical Company. All the chemicals were used 
without further purification, and the HSA molecular weight was assumed to be 
66 500 g/mole to calculate the molar concentrations. All other reagents were of 
analytical grade, and doubly distilled water was used throughout all the 
experiments. 
3.2.8 Solutions and Sample Preparations 
 
     The working solution of oxaliplatin  (5.0 x 10-5 M) and HSA was obtained by 
appropriate dilution of the stock solution with phosphate buffer. Phosphate 
buffer solution containing 0.1 Mol NaCl was used to keep the pH of the solution 
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at 7.40. The prepared sample solutions were incubated in a water bath at 370C 
prior to the experiment. 
 
3.3 Results and Discussion 
 
     Raman spectroscopy has been shown to be a powerful tool in structural and 
conformational analysis of proteins 26. The application of this technique to study 
the interaction between oxaliplatin and HSA could help in the understanding of 
the mechanism of the interaction and action of the drug. The Raman spectrum 
of a protein such as HSA, arises from the peptide backbone and various amino 
acid side chain groups.   Since the structure of HSA is stabilized by 17 
disulphide bridges and one free Cys residue, the investigation of the change of 
the disulphide bond is very critical 27. Two groups of Raman markers  of HSA 
are used to  confirm the alteration of  the HSA structure: (1) disulphide bridges 
and (2) Amide-I and Amide-III of  the polypeptide chain of HSA. In the 
secondary structure of protein, bands related to amide-I attribute to C=O, while 
the oscillation of N-H contribute to  Amide-III.  
 
3.3.1 Raman measurement of HSA, oxaliplatin and HSA-
oxaliplatin complex using 633nm excitation. 
3.3.1.1 Disulphide bridges 
     Fig. 3-6 shows the Raman spectrum of HSA in the region of 300-800 cm-1.  
The bands in the spectra range  400-700 cm-1 are attributed  to the stretching 
vibrations of  C-S groups, and the vibrational modes in the range of 600-400 
cm-1 are attributed to the S-S groups 27. However, all these Raman bands 
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decreased after incubation with oxaliplatin, indicating distortion or breakage of 
the disulphide bridges ( Fig 3-7). According to our previous work28, using  CIEF 
, UV/Vis and fluorescence  , the structural distortion of HSA was demonstrated 
in a variety of incubation ratios.   
       In Fig 3-6, a weak Raman band observed at 507 cm-1, attributed to ggg 
geometry, predominated in Cys-SS-Cys residues, while weaker bands at 540-
536 cm-1 and 518 cm-1 indicated other conformations. As described above, we 
have identified two disulphide stretching bands at ~518 and ~507cm-1 (Fig 3-6), 
and the Raman frequencies are similar to those reported previously29.  
 
Figure 3-6. Raman spectrum (300-800 cm-1) of HSA (5.0 x 10-5 M) in 
phosphate buffer at pH 7.40. The spectrum acquisition time was 20 sec. 
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Figure 3-7. Analysis of the S-S Raman band of HSA (5.0 x 10-5M) , with 
oxaliplatin in 1:10 molar ratio. The spectrum was collected under physiological 
conditions ( in phosphate buffer at pH 7.40, 0.10M NaCl).  
 
Monitoring the spectral range 300-800 cm-1, results in a spectral 
evolution by which the protein S-S may be distorted or there is a breakage of the 
disulfide bridge. The interacted HSA shows a stronger and broader Raman band 
at 516 cm-1 , while   new bands emerged  near 600-700 cm-1. HSA has several 
weak Raman features in the region 600-550 cm-1that could be attributed to 
aromatics. The unusual broad peak at 516 cm-1 may rather be a consequence of 
breakage of the S-S bonds. Indeed, the breakage of the disulfide bond can 
significantly affect the local couplings of the internal coordinates, thus 
modifying other vibrational modes. With respect to the peak identified here, the 
question remains as to whether it represents the complex formation between 
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HSA with oxaliplatin or whether it is the result of an arbitrary decomposition of 
the protein. In the same context, it is worth emphasizing that the appearance of 
new peaks in the range of 600-664 cm-1 is attributed to bands from the drug. 
However, a significant Raman shift was observed compared with the oxaliplatin 
spectrum prior to mixing with the protein (Fig 3-7). This result suggests that due 
to the presence of the drug, the HSA molecule may undergo a structural 
rearrangement and possibly structural decomposition under the drug load.  
Although the above conclusions are of intrinsic interest, they can probably be 
amplified by more extensive analyses of the spectra. 
 
 3.3.1.2 Amide-I and III 
Concerning the binding of ligands to HSA molecule, there are 
conformation rearrangements, which can be rather considerable. Conformation 
rearrangements are possible  in the whole molecule of HSA, not only in the 
binding region. For an estimation of the structural state of protein molecules 
oscillations of modes of Amide - I and Amide - III in the  Raman spectra are 
used. These are oscillations of the main polypeptide chain.      
The Raman spectrum of HSA is presented in Fig 3-8 which shows the 
strongest bands at 1655 cm-1, 1276-1270 cm-1(α-helix) and weak bands at  
1264-1256 cm-1 (α-helix or random) 30. In addition, the line at 941 cm-1 is 
attributed to a CC stretching vibration, associated with helical conformation. 
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Figure 3-8  Raman spectrum of HSA (5.0 x 10-5 M)  in the range of  1000-2000 
cm-1 before incubation with oxaliplatin. The spectrum has been smoothed and 
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Figure 3-9. Raman spectrum of HSA after incubation with oxaliplatin.        
HSA (5.0 x10-5M) was incubated in 1:10 molar ratio with oxaliplatin             
(5.0 x 10-5M). The incubated solution was kept at 370C for 1h before being 
inserted into the Teflon tube. 
 
The analysis of the Raman spectrum of the native HSA in the amide I 
spectral region is shown in Figure 3-8. The amide I band of HSA, situated 
between 1610 and 1700 cm-1, belongs primarily to the CO stretching mode and 
is dependent on the molecular environment of the protein. This mode is also 
sensitive to the protein secondary structure.   This arises due to the dependence 
of the inter peptide vibration coupling and the arrangement of H-bonds on the 
secondary structure 29.   The peak centered at 1655 cm-1 is sharp,  and strong, 
and 1256-1276 cm-1 is attributed to amide III.  On addition of oxaliplatin  at 
values of solution,   intensity decreases for peaks in the ranges 1256 – 1276 
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cm−1 and 1270 – 1280 cm−1 are observed. This effect was also observed for 
peaks in the range 1645-1655 cm-1. In addition,  disappearance and appearance 
of peaks is observed for all the spectral ranges, while the area under the curve is 
increased for  both amide I and III spectral regions. All these changes are related 
to the disassociation of the protein upon interaction with oxaliplatin. As already 
mentioned in the previous section, the breakage of the S-S bridge can 
significantly affect the local couplings of the internal coordinates. Many of 
these new peaks probably correspond to the protein, whereas others may be due 
to the structural modification undergone by oxaliplatin in the complex 
formation with HSA. 
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Figure 3-10. Raman spectra of HSA before and after incubation with 
oxaliplatin in molar ratio1:10.
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 3.4 Liquid core waveguide (LCW) using high performance 
Raman spectroscopy under illuminated conditions from a 
distance of 70cm using 785nm laser line 
 
3.4.1 Intensity of Raman Radiation 
        The  intensity of Raman radiation produced by LCW tube in backscattering 
geometry has been predicted to vary with the length of the tube according to the 








−−=                                                                               (3) 
 
Where PR is the Raman power, PL is the laser power, α is the (base-e) LCW loss 
coefficient, х is the LCW tube length, and K is a constant related to the 
scattering cross-section of the core liquid and collection angle inside the LCW 
tube. Equation 3 suggested that the loss coefficient is the same for both the laser 
and Raman scattered radiation. 
3.4.2 Raman spectral features of Teflon® AF 2400 tube and 
water 
Fluorescence background in Raman measurements is more common and 
more significant than with conventional small path length tubes. The numerical 
aperture (NA) of an optical fiber depends on the difference of the squares of the 
refractive indices of the clad and core regions (Fig 3-11). In this vein, the light 
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throughput in a liquid-filled AF tube is highly dependent on the refractive index 
of the liquid in the tube.  










































Figure 3-11. Relation between NA and RI of opticalfibre. 
 
The RI of the AF tube functioning as the “cladding” region of the optical 
fiber, of course, remains constant. The RI of the solution in the tube is always 
higher than the RI of the AF tube. Accordingly, the numerical aperture and the 
light throughput increase dramatically with increasing RI of the inner solution.  
 
 
222 ~~ clc nnNAP −                                                        ( 4 ) 
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Where P is  the laser power, NA is the numerical aperture of the optical 
fibre , nc and  ncl are the  refractive index of the core and the clad of the optical 
fibre. 
 
       The Raman spectrum of Teflon® AF tube excited using 785 nm laser line is 
shown in Fig.3-10. The molecular structure of the Teflon AF 2400 and its 
Raman spectrum are shown in Fig 3-12. A major problem in LCW–RS is the 
background fluorescence from the Teflon tube and water, which easily masks 
the weak Raman signals. This broad band fluorescence covers most of the 
visible region of the spectrum and reaches a maximum near the center of the 
visible region. Fluorescence is often orders of magnitude stronger than the 
inherently weak Raman scattering effect, and broad and strong fluorescence 
bands due to the presence of one or several fluorophores often lead to detector 
saturation before adequate Raman signal intensity is obtained. Teflon-AF 
fluoresces strongly when excited with a visible laser lines such as 488 or 514 
nm. As shown in the enlarged plots in Fig 3-11, Teflon-AF has Raman bands at 
725, 788 and 843 cm-1.  These spectra clearly demonstrate that, peak 
overlapping is possible.   However, there are two approaches we adapted to 
minimize this background: switching the excitation wavelength either to the 
(near)-IR region and using extensive Teflon-water subtraction criteria to 
minimize the interferences.  
 
 80





6 0 0 6 5 0 7 0 0 7 5 0 8 0 0 8 5 0 9 0 0
R a m a n  s h i f t  ( c m - 1 )














Figure 3-12.  Raman spectrum of empty Teflon® tube AF 2400 acquired with 
785 nm excitation line. The inset shows Teflon AF polymer structure. 
 
     The water Raman spectrum is relatively weak and flat at the fingerprint 
region of the spectrum which is 300 to 1500 cm-1. We compared the Raman 
spectra of Teflon-AF collected with water and buffers. Water shows somewhat 
greater fluorescence intensity when compared with Teflon-AF when collected 
from the Teflon-AF tube. This indicates that our background intensity is 
primarily due to water itself, rather than to the Teflon-AF tube. There is a 
similar conclusion from the published Raman spectrum of water. In addition, 
the three Teflon-AF bands show minor or no interferences due to the weak 
signal compared to the sample peak.  
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   Table 3-1. Refractive indices of various solvents and cell materials. 
Solvents and cell materials Refractive index  (nd)a 
Teflon® AF 2400 1.29 









Ethyl acetate 1.370 
n-Hexane 1.372 
2-Propanol 1.375 






Quartz glass 1.458 (18ºC) 
Carbon tetrachloride 1.459 








a Note: 25ºC Unless otherwise stated. The values are cited from reference 30. 
bFEP:  
CNo data on temperature 










3.4.3 Remote spectral measurements with fiber-optic coupled 
with LCW-RS from a distance of  70cm 
 
 To demonstrate the signal enhancement made possible using the  
LCW-RS, Raman spectrum of cyclohexane aqueous solutions are shown in  
Figure 3-13. The Raman spectrum of liquid cyclohexane  was collected in the 
350-3200 cm-1 region.  Most organic solvents are strong Raman scatterers and 
have several Raman bands; such features make them ideal for calibration 
purposes, and they are inexpensive. Note that the cyclohexane bands are 
relatively well separated from the Teflon AF tube bands, and should not 
interfere with the three bands.  For this experiment, the laser power at the 
sample was maintained in the range of 10-20 mW.  This range of power was 
kept throughout the experiment, since powers exceeding >20 mW can melt the 
Teflon tube.  Smaller diameter LCW tubing usually generates high power 
density per unit cross section when exposed to high laser power. This power 
limitation often restricts to using higher laser power for the application of this 
technique to investigate protein samples such as hemoglobin or HSA.  An 
attempt was made to measure Raman signals from a variety of protein samples. 
It was found that due to the structural complexity of the proteins, a high energy 
laser power is required to probe the Raman active species of the proteins. 
Additionally, low solubility and denaturing at high power limits the technique 




 The higher intensity Raman spectrum of cyclohexane, shown in  
Figure 3-13 , was collected in a 5 cm, 150 i.d. Teflon AF waveguide at a 
distance of    70 cm from the collection lens using a hyper sensitive 
spectrometer by P&P Optica31 .  In this mode, 1µL sample was injected into a 
5cm Teflon® AF tube using a disposable syringe (1mm). Measurements usually 
consisted of five replicate cyclohexane spectra. A sample of typical results is 
presented in Table 3-2. The positions of these Raman peaks shown in Fig.3-13 
are within ±2 cm-1 of the values reported in the literature 30.  However, the lower 
intensity of cyclohexane spectrum, shown in Figure 3-13b, was due to the 
detector sensitivity weakening as we approach the CH asymmetric and 
symmetric bands (Fig.2-5). The strong Raman peak at 802 cm-1 (CH2  
deformation + ring mode) was used to evaluate the performance of the LCW-RS  
vs  cyclohexane spectrum published by  Sigma-Aldrich® 32.  
Fig 3-13 shows typical spectra of cyclohexane recorded with the LCW-
RS  fiber-optic coupled system collecting at a distance of 70 cm, where the 
strong fingerprint Raman lines of cyclohexane  (385 and 1600 cm-1) are well 
resolved. The Raman signal intensity from the spectrum of cyclohexane  in the 
LCW-RS was greatly enhanced over the spectrum collected by Sigma-Aldrich.  
It should be noted that the cyclohexane spectrum was acquired with 1s exposure 
time.  The intensities of the Raman peaks at 802 cm-1 were calculated after a 
background correction was performed to remove Raman scattering due to the 
water and the Teflon® AF tube.  Even without the background substraction 
procedure, the cyclohexane spectrum shows a good signal to noise ratio (S/N)  .  
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This may be due to the fact that the LCW provided an excellent enhancement 
effect due to  the low refractive index of the Teflon AF tube compared with 
other solvents and materials ( Table 1)  . Once again, the distance Raman 
system has been shown here to detect all of the major Raman bands present in 
the sample in a very short period, including the Raman bands at 1500-2300 cm-1 
which is absent in the spectrum published by Sigma-Aldrich®32.  
 
 
Figure 3-13. Comparison of  source and target spectrometers, based on a view 
of comparable spectra. (A) Cyclohexane fingerprint spectrum from Sigma-
Aldrich®32. (B) Cyclohexane spectrum in 5 cm long, 150 µm i.d., 360 µm o.d. 
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acquired with  λ=785 nm , the laser power at the sample was 15 mW and the 
acquisition time was  1 s. 
 
A comparison of the two spectra in Figures 3-13(A-B) show that all 
features of the LCW-RS spectrum are both present and enhanced in the 
waveguide spectrum.  The spectra compare quite favourably to those using 
conventional delivery and collection optics. Note, there are also no extraneous 
peaks in the waveguide spectrum from the Teflon AF tubing. When the laser is 
properly launched into the core of the waveguide, there is minimal Raman 
scattering collected from the Teflon AF waveguide cladding.  






385 a1g Ring mode 
428 eg  
CCC deformation + CC 
torsion 
802 a1g CH2 deformation + ring mode 
1025 eg CH2 deformation + ring mode 
1155 a1g CH2 deformation 
1253 eg CH2 deformation 
1345 eg  
1443 eg CH2 scissors 
1596 eg CH2 scissors 
2855 a1g CH2 symmetric stretch 
2895 eg CH2 stretch 
2930 a1g CH2 symmetric stretch 
2941 a1g CH2 symmetric stretch 
 
 
To further demonstrate the effectiveness of the LCW-RS, a more 
complicated mixture of similar alcohols was investigated. Figure 3-14 shows the 
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Raman spectra obtained for a mixture of five to six alcohols injected into the 
Teflon AF tube, where the strong fingerprint regions of Raman lines of these 
alcohols (400-1600 cm-1) are well resolved. Individual sample peaks are narrow 
relative to their target counterparts. However, such similar structural profiles 
pose great challenges to distinguish individual spectral features from the plot 
(Figure 3-13). The distinctive molecular fingerprint of each alcohol is evident 
from Figure 3-13. It is possible however to distinguish these alcohols with  the 
same functional group, e.g., ethanol (C2H6O) and 1-butanol (C4H10O) from each 
other by using the positions of the  finger print region. Figure 3-13 compares all 
the spectra of the six alcohols, which have hydroxide as the common functional 
group but different structures. 
The Raman spectra of methanol, 1-butanol, ethanol, isopropanol, 
 5-pentanol and 1-hexanol are shown in Figure 3-14. The vibrational 
assignments are as follows: The region between ~1000 and ~1260 cm-1 contains 
the bands associated with the C-C and C-O stretches.33 The C-O-H bending 
band occurs between ~1200 and ~1450 cm-1.33 The CH3 bend occurs at  
~1460 cm-1, and the bands associated with the C-H stretches appear between 
~2840 cm-1 and ~3000 cm-1 ( not shown).33Notice in Figure 3-14 and b the 
overlap of   some of the bands when the data is plotted on the same axis. 
However, their distinct spectral features allow for positive identification using 














3.5  Application of CIEF-LCW by the combined 
Raman/fluorescence spectrometer  to measure fluorescence 
spectra of proteins using  488nm excitation line 
Raman spectrometers have a high spectral resolution of about 5 cm-1 over 
the wavenumber range of 788–1049 nm ( 48-3206 cm-1), while fluorescence 
spectrometers have high spectral resolutions of 0.4 and 0.1 nm over the 
wavelength range of 486–757 nm ( 84-7264.3cm-1), respectively. In particular, 
the signal-to-noise ratio of Raman spectroscopy has been improved by using a 
volume phase holographic (VPH) diffraction grating and a liquid-nitrogen-
cooled charge-coupled device detector. The performance of the combined 
spectroscopy system has been demonstrated by taking fluorescence 
measurement on highly fluorescent two diverse protein molecules,  
R-phycoerythrin (RPE) and fluorescein isothiocyanate (FITC)-labeled human 
serum albumin (HSA).  
The details of the optical configurations of the apparatus and the separation 
cartridge will be described in detail in Chapter 4 (section 4.2.1). However, for 
the fluorescence measurements, the separation capillary was replaced by the 
Teflon AF tube.  To discuss the results obtained from the fluorescence 
measurements it is necessary to consider two major factors that influence these 
values, i.e,, the performance of the high sensitive spectrometer and LCW 
enhancement factor  in the presence of high refractive index species (Table 3-2). 
As has been pointed out in previous sections, the high performance of   our 
system was demonstrated using selected samples as an example. This is 
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especially important for the implementation of this technique to wide areas of 
applications. 
The results of the capillary isoelectric focusing in the LCW tube with two 
different fluorescence proteins  with ampholyte  ( pH 3-10) are shown in Figs. 
3-15 and 3-16. These low molecular weight ampholytes help to facilitate the 
formation of stable gradients across the tube. The concentration of the two 
samples was kept very low to avoid sample absorption on the wall of the tube 
and attenuation of  the laser intensity along the tube. Higher sample 
concentration also affects the TIR by absorbing the propagating light 34.  





















Distance from Anode (cm)
HSA-FITC
 
Figure 3-15.  CIEF of FITC-labeled HSA 10 µg/mL.  The sample containing 
2% pharmalytes (pH 3–10) and 0.5% PVP. Separation capillary: 5 cm, 150 i.d. 
Teflon® AF 2400 capillary. Applied voltage: 0–5 min, 1 kV; 5–15 min, 3 kV. 
Excitation: Argon ion 488 nm at 5-10 mW.  
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As the result shows in Fig 3-15, the concentration of the protein was 
kept low to avoid the problems stated above. HSA-FITC is FITC labeled protein 
with a maximum excitation wavelengths 488 and 520 nm., respectively. FITC 
labeling is frequently used to improve sensitivity of protein analysis by capillary 
electrophorsis . After 10 min of focusing time, the fluorescence spectrum of 
HSA-FITC revealed a multiple peaks at its isoelectric point. Both proteins 
(HAS-FITC and RPE) were separated in an isoelectric focusing medium. The 
locations of the peaks match reasonably well to those published results, but the 
observed multiple peaks are not consistent with those that reported.34  The main 
reason to such performance enhancement was the use of advanced optics and 
the unique system approach that dramatically improves the system efficiency. 
The fluorescence spectrum shows several distinctive features.  This 
provides evidence that more than one amine sight can be bonded with FITC 
during the derivatization procedure on the protein.  The appearance of the 
multiple peaks also suggested the possible Raman scattering bands associated 
with the observed peaks.  It has been reported that the Argon laser 488 nm line 
generates Raman scattering centered at 495 and 575 nm and these modes 
interfere with the fluorescence signal 35. This interference can also generate a 
significant background signal associated with water or other solvent. The broad 
peak observed for HSA-FITC also likely due to the multiple labeling. The laser 
power was maintained throughout the experiment at 1-10 mW to avoid any 
sample damage due to photobleaching.  
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Figure 3-16.   CIEF of RPE sample 5µg/ mL RPE; containing 2% pharmalytes 
(pH 3–10) and 0.5% pvp. Separation capillary: 5-cm x150 µm i.d. Teflon AF 
2400 capillary. Other conditions as in Fig. 3-15. 
 
R-phycoerythrin (RPE) was selected as the second model protein to 
investigate the CIEF-LCW fluorescence capability of the instrument. An 
excellent separated with a good peak shape was obtained after 10 min focusing 
time (Fig3-16). Although, the fluorescence spectrum shows a good peak shape, 
similar to the previous result, a strong background was observed. As already 
discussed above, Raman scattering or Raleigh tail can be responsible for the 
observed background. This required more investigation to understand the nature 




3.6 Limitations of LCW-RS  
      While the LCW coupling with the Raman spectrometer system described 
here provides very accurate and sensitive Raman measurements of dilute 
aqueous samples, the field of waveguide-enhanced aqueous Raman 
spectroscopy is still in its infancy, especially for biological applications. One 
limiting factor is that techniques for manufacturing high-quality optical 
waveguides from Teflont-AF are not yet optimized. Sample absorption and 
degradation of the Teflon tube at higher laser powers also restrict the universal 















The evaluation of a high performance LCW-RS can be characterized in a 
number of ways. During the course of our work developing and characterizing 
the new system, the simplicity of this method, the reasonable Raman signal 
enhancement, combined with the high degree of reproducibility with the analyte 
and small sample volumes required, make it a promising candidate for sensitive 
low-power identification of several species including biological samples. 
  The LCW-RS using a high performance spectrometer is a promising 
technique for studying protein characterization and investigation of drug-protein 
interactions. In this study the structural changes of HSA under action of the 
antitumor drug was investigated by the Raman spectroscopic method. Our high 
performance Raman spectrometer has been adapted for measuring spectra in 
visible and NIR spectral ranges. This spectrometer was demonstrated to have 
superior stability, simplicity and accuracy, large throughput, cost efficiency and 
sensitivity compared to those of a multichannel dispersive Raman spectrometer.  
Using this technique, we have investigated the interaction of oxaliplatin 
with HSA through two different sites (S-S disulfide bridge and amide I and III). 
In the case of S-S, the spectral region of S-S disulfide bonds indicates the 
breakage of the bond that results in the rearrangement of the protein structure. 
Furthermore, the amide I and III regions indicate that, the drug induced a 




Consequently, it has been demonstrated that the present system enables 
one to measure Raman and fluorescence signals with sufficient reproducibility 
from run to run. With use of this system, we measured the Raman signal and 
fluorescence at a distance of 70 cm. A comparison of the relative efficiency of 
the system compared to conventional techniques has been presented here. It 
should be noted that the present successive measurement has the advantage of 
observing Raman signals and fluorescence easily. In the traditional way for 
measuring Raman signals, expensive and complicated optical configuration is 
required. With the present system, on the other hand, relatively strong Raman 
signals are obtained with a simple optical configuration. We have also shown 
that simultaneous measurements of Raman signals and fluorescence signals  
( or absorption if necessary) can be achieved  by removing only the laser filter. 
In particular, the combination of the LCW and the inexpensive high 
performance spectrometer can provide highly sensitive and convenient routine 
analytical systems.  
Finally , this work describes the first step towards  the potential 
application of the  high performance spectrometer  system for  coupling with 
CIEF and at the same time  perform Raman spectroscopy studies. The two 
dimensional array opens completely a new way to investigate or characterize 
proteins using CIEF. Furthermore, this spectrometer should replace the 





INVESTIGATION OF  INTERACTION BETWEEN HUMAN 
HEMOGLOBIN A0 AND PLATINUM ANTICANCER DRUGS BY 
CAPILLARY ISOELECTRIC FOCUSING WITH WHOLE COLUMN 
IMAGING DETECTION* 
4. 1 Introduction 
          Platinum-based drugs are among the most active anticancer agents and 
have been widely used in the treatment of a variety of human tumors. Over the 
last 30 years, a large number of platinum analogues have been synthesized to 
enlarge the spectrum of activity, overcome cellular resistance, and/or reduce the 
toxicity of both first (i.e. cisplatin) and second generation (i.e. carboplatin) 
platinum drugs1.  
 
*The result presented in this chapter have been published: 
Tibebe Lemma,  Rupasri Mandal , Xing-Fang Li, and Janusz Pawliszyn 
Investigation of  Interaction between Human Hemoglobin A0 and Platinum 
Anticancer Drugs by Capillary Isoelectric Focusing with Whole Column 
Imaging Detection. Journal Separation Science ,21, 1803-1809, 2008 
 
 Unless otherwise stated, all of the work reported in this chapter was performed 




Of these platinum-based compounds , oxaliplatin, a novel compound 
containing a trans-1-(R,R)-1,2-diaminocyclohexane (DACH) (Fig.4-1) carrier 
ligand, has recently been approved for the treatment of metastatic colorectal 
carcinoma in conjunction with fluoropyrimidines 2. Oxaliplatin has shown in 
vitro and in vivo efficacy against many tumor cell lines and tumors, including 
those that are resistant to cisplatin and carboplatin 1, 3-5.  
In addition to its positive effects oxaliplatin also shows several toxic effects. 
The main cumulative dose-limiting toxicity of oxaliplatin is progressive 
peripheral sensory neuropathy 6, 7. It is also associated with an acute neuropathy 
mild which reverses in several hours or days 6, 7. Oxaliplatin can also produce 
diarrhea, vomiting and hematological suppression7, 8. However, the 
mechanisms of action and toxicity are not clear. 
          Pt-containing anticancer drugs are believed to induce apoptosis in cancer 
cells by covalently binding to DNA 9-11, however, they also react with a number 
of proteins and peptides, such as glutathione, which may also play a role in 
detoxification of oxaliplatin 12. In addition, after these drugs are introduced 
intravenously, 65 – 98% of the drugs are bound to blood plasma proteins 13-15, 
and 40% of the blood platinum is found in erythryocytes 15, 16. While it is 
widely accepted that Pt-DNA adducts are responsible for the drug’s 
cytotoxicity, the role of Pt-protein adducts in the mechanism of action and 
toxicity of the drug remains unclear. Platinum-protein adducts are suggested to 
be the cause of the drug’s side effects; however, there are also claims that they 
are important to the drug’s activity 17.  Therefore, information on how 
anticancer drugs interact with proteins is important for the understanding of the 
mechanisms of action and toxicity of a drug and the optimization of cancer 
treatments.  
 
Figure 4-1. Major oxaliplatin and cisplatin metabolites. 
 
        The dominant adult hemoglobin (Hb Ao)  exists as a noncovalent tetramer 
consists of two α ( 141 amino acids; 15 126.4 Da) and two β(146 amino acids; 
15 867.2 Da) polypeptide chains  and a heme group is bound to each of the 
chains through noncovalent interaction16. Recently, the formation  of Hb-Pt 
complexes and the release of heme group from Hb was determined using size 
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fractionating, size exclusion, high performance liquid chromatography- 
inductively coupled plasma mass spectrometry ( HPLC-ICPMS), and nanospray 
mass spectrometry (MS) 18. The information obtained from this study suggested 
the heme dissociation induced by Pt drugs may be important to improved 
understanding of side effects (e.g.anemia) of the cancer patients undergoing such 
treatment because the heme group binds molecule of oxygen and  carrying 
oxygen from lungs to different tissues. Therefore,  investigation of the structural 
alteration of Hb induced by Pt, and studying the nature of the complex formed 
will add significantly to the success of understanding the mechanism of action 
and toxicity of the drugs. 
        Advanced analytical techniques and methodologies are essential for 
obtaining this information. Nowadays, there is strong concern in the anticancer 
research community regarding improvement of the analytical techniques in use. 
This led in particular to a growing number of metallodrug-protein investigations 
performed using valuable techniques superior to contemporary methods in the 
field. A recent review summarizes the progress made in the applications of 
modern analytical methodologies for antitumor metallodrug-protein studies 19. 
Electrospray ionization mass spectrometry (ESI-MS) was recently shown as an 
extremely useful tool for studying the cisplatin-protein interactions18, 20-24. As 
well, high performance liquid chromatography (HPLC) 18, 23, 25-27and a 
complementary high-resolution technique with an orthogonal separation 
mechanism, capillary electrophoresis (CE)28-30, are growing in importance for 
characterizing the protein binding for different metal complexes. The potential 
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of resolving intact and protein-bound drug forms appears to be prominent when 
combined with a metal-specific mode of detection by using inductively-coupled 
plasma mass spectrometry (ICP-MS)18, 24, 26-28. 
       Capillary isoelectric focusing (CIEF) provides high resolution separation of 
amphoteric biomolecular species based on differences of their isoelectric point in 
a pH gradient formed by carrier ampholytes, when an electric potential is applied 
31 . This high-throughput technique offers greater resolving power and becomes 
a standard method for analysis of protein and protein-ligand interaction. The 
utilization of the whole column detection approach with UV WCID gives this 
separation technique a unique advantage over the conventional single point 
detection 31-34. For example, in single point detection, several problems are 
encountered during the sample mobilization process, including protein 
precipitation, long analysis time and distortion of pH gradient. In contrast, CIEF-
WCID successfully eliminates the mobilization process by using the WCID 
technique.   
        Owing to the merit of on-column detection and the capability of attaining 
real-time monitoring of the changes in peak area, CIEF-WCID is suitable for 
protein-protein and protein-drug interactions. Recently  CIEF-WCID has been 
successfully applied in our group to investigate protein-DNA 35, protein-amino 
acids 36 and protein-lipids 37-40 interactions. Furthermore, we demonstrated the 
use of this technique to determine the molecular weight of unknown proteins  41. 
CIEF-WCID is expected to make a unique contribution in proteomic research 
because of its ability to resolve wide ranges of proteins and protein complexes 
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that have small differences in pI in real-time. This technique is very important 
when one studies protein- ligand interactions such as protein-protein, protein-
DNA and protein-drug. 
         The development of efficient and sensitive analytical methods for the 
separation, identification and quantification of drug-protein adducts is 
paramount for understanding the drug activity and toxicity.  The objective of the 
preset study is to develop a CIEF-WCID to investigate the interactions of Pt-
containing anticancer drugs, cisplatin and oxaliplatin with a model blood protein, 
human hemoglobin (Hb). The structural changes of the Hb is investigated by 
monitoring the pI during the incubation of oxaliplatin and cisplatin with Hb. 
CIEF is the highest efficiency single dimensional separation method available 
for the investigation of the interaction between proteins and ligands. This 
technique offers a number of advantages, including speed, high separation 
efficiency, short analysis time and reduced sample consumption. Although the 
CIEF technique shows a number of advantages, quantitative information was 
chiefly provided by other techniques. 
        To our knowledge, the investigation of cisplatin or oxaliplatin interaction 
with Hb by CIEF with WCID is the first report of this type of analysis. The 
development of a simple and reliable method to study drug-protein interactions 





4. 2 Experimental 
4.2.1 Apparatus 
         The CIEF experiments were carried out on a commercial iCE280 instrument 
(Convergent Bioscience, Missisauga, Canada).  The system was equipped with a 
CCD camera for image collection. Separations were performed on commercial 
cartridges with silica capillary tubes (Convergent Bioscience), with an effective 
length of 5 cm, 100 µm I.D. and 200 µm O.D.  The capillary wall was coated 
with fluorocarbon (Restek, Bellefonte, PA, USA) to suppress the electro-osmotic 
flow (EOF). Focusing was carried out for 2 min at 500V, and the system was set 
at 3000V for the remainder of the analysis. The catholyte and anolyte contained 
1% PVP with 100 mM NaOH and 100 mM of H3PO4, respectively. The sample, 
which was mixed with 0.5% pvp and 2% ampholyte (pH 3 -10), was manually 
injected with a needle. To avoid  inconsistent coating efficiency, all capillaries 
were dynamically coated with additives for thirty minutes prior to the 
experiment. During the focusing process, the current was decreased from 















          [SP-4-2-{1R-trans)]-(1,2-Cyclohexanediamine-N,N') 
[ethanedioata(2-)-O,O']platinum (oxaliplatin) (99.9%), cis-Platinum(II) 
diammine dichloride (cisplatin) (99.9%), carrier ampholytes (Pharmalytes 3.0-
10.0), and human hemoglobin Ao were purchased from Sigma (St. Louis, MO, 
USA). Polyvinylpyrrolidone (PVP) was purchased from Aldrich (Milwaukee, 
WI, USA). Water was purified with a NANOpure water system 
(Barnstead/Thermolyne, Dubuque, IA, USA) and had a minimum resistivity of 
18.0MΩ-cm. 
4.2.3 Solutions and Sample Preparation 
          Stock solutions of oxaliplatin and cisplatin were prepared with a 
concentration of 5 mmol/L. The Hb stock solution was prepared with a 
concentration of 25μmol/L. The stock solutions were freshly prepared every day. 
All reaction mixtures were prepared in duplicate. 
 
4.2.4 Incubation of Hb with Oxaliplatin and Cisplatin 
           Samples containing a fixed concentration of Hb (10µmol/L) and different 
concentrations of oxaliplatin and cisplatin (0-100µmol/L) were incubated at 
37oC for a maximum of 3 days.  The concentrations of the drugs used in this 
study were below and above the drug content in the blood. The solutions of Hb, 
oxaliplatin and cisplatin were prepared in 0.1M phosphate buffer pH 7.4 
containing 10μmol/L NaCl.  The pH values of all reaction mixtures were 
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maintained at pH 7.4 to mimic physiological conditions.  The molar ratios of the 
incubated protein:drug  solutions were 1:1, 1:10, 1:50 and 1:100. The high drug-
protein ratios were used to ensure the complete ( equilibrium) binding 
conditions. 
4.2.5 Preparation of Erythrocyte Samples from Patients and 
Healthy Volunteers 
Blood samples from colorectal  and lung cancer patients were collected 
1 and 48 h after the first infusion of oxaliplatin42. The dosage of oxaliplatin was 
100 mg/m2 in 500 mL of 50g/L dextrose in water, infused over 120 min. 
Written informed consent was obtained from the patients. The protocol was 
reviewed and approved by the Research Ethics Board of the Alberta Cancer 
Board. In addition to the samples from cancer patients, blood samples from 
healthy volunteers were also collected as controls. Wholeblood samples from 
both patients and volunteers were collected in lithium heparin–coated tubes. All 
samples were centrifuged at 2500g for 15 min. The erythrocyte layer was 
separated from the plasma layer according to the published method 43. The 
erythrocyte and plasma samples were placed separately in cryovials and then 
stored at -35 °C until analysis.  
 
4.3 Results and Discussion 
4.3.1  Oxaliplatin- Hb  interaction 
          The applicability of the CIEF-WCID technique for the study of the 
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interaction of two anticancer drugs ( cisplatin and oxaliplatin) with Hb  at near 
physiological conditions was evaluated.  For this work, mixtures containing a 
constant concentration of Hb (10µmol/L) and different concentrations of 
oxaliplatin (0-100µmol/L) were incubated at 37oC for a variety of incubation 
periods.   The experiments in this study were performed in parallel with a control 
Hb sample (drug free Hb ), incubated under the same conditions as the sample 
mixtures.  The reaction mixtures of Hb-oxaliplatin were injected into the 




Figure 4-3.The CIEF analysis of Hb A0 (10µmol/L) incubated for 3 days at 
37oC.  For the CIEF analysis, a sample solution (400µL) containing 2% 
pharmalytes (pH 3.0-10.0), pI markers (pI 6.14 and 8.40) and 0.5% pvp was 
injeced into the capillary by pressure using a syringe. The catholyte and anolyte 
were 100mM NaOH and H3PO4 consecutively. The focusing voltage was set at 
500V for 2min and 3000V for the remainder of the focusing period. 
 
Figure 4-3 illustrates drug free Hb  (control) separated by CIEF 
containing two pI markers (6.14 and 8.40). It should be mentioned that the two 
pI markers were used to observe possible pI shifts during the incubation 
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progress.  In the absence of the drug, the electropherogram contains two 
distinctive peaks, which are characteristic of Hb. The pI values of the two peaks 
are 7.13 and 7.27. As shown in Fig.4-3, no structural change was observed for 
the first 12 hours of the incubation period. However, as time progressed (after 24 
h), the two peaks began to change profiles and a third peak became visible.  This 
may suggest that the surface property of Hb was altered.  
        The CIEF profiles for the reaction mixtures that contained Hb-oxaliplatin, 
is shown in Figure 4-3(a-d) . On the basis of the CIEF profile in Figure 4-3, two 
peaks are identified as the major components of Hb and focused at the pI (7.13 
and 7.27). Figure4-3a-b shows the electropherograms of the incubated reaction 
mixtures with two molar ratios, 1:1 and 1:10. The Hb-oxaliplatin incubated in a 
1:1 molar ratio exhibited the same pattern and similar pI values as the control 
sample (Fig. 4-2). However, the intensities of the three peaks, which appeared 
after 12 h, are lower compared to the control. Short-term (0-8h) incubation of Hb 
with oxaliplatin metabolites in a 1:1 ratio did not exhibit a significant change in 
the protein structure, whereas longer incubation periods (12-72h) resulted in a 
distortion of the complex. This indicates the stage at which the adduct is formed 
between the two analytes.  In contrast, although a similar CIEF profile was 
observed during the first 8h in the sample with a 1:10 ratio, peak distortion and 
degradation of the adducts occurred after 12h.  When the incubation time 
reached 48h, the adduct peak completely vanished. This clearly illustrates the 
formation of Hb-drug adducts and the change in pI of the protein. The observed 
pI change is estimated to be of the order of 0.006-0.19 pH units (Table 4-1). One 
possible explanation for the disappearance of the peak is that it results from the  
loss of iron or the heme group  resulted the conformational change of the 
protein. It has been suggested that the target protein can be adducted by multiple 






Figure 4-4. Electropherograms representative of binding of human hemoglobin 
A0   with oxaliplatin : (a) 1:1 ; (b) 1:10 ; (c) 1:50 and (d) 1:100 molar ratios . The 
drug-protein mixture were incubated for 3 days at 37oC. Appropriate amounts of 
the incubated samples were removed and mixed with 0.5% PVP, 2% 
pharmalytes (pH 3.0-10.0) for each CIEF run. Catholyte and anolyte were 
100mM NaOH and H3PO4.  
 
          The pI shift and the drug-induced disappearance of the peaks, provide 
striking evidence of strong and kinetically fast interactions of the protein with 
oxaliplatin. The time dependent decreasing pattern was observed for all peaks, 
along with progressively decreasing peak intensities (Fig 4a-b). As the drug-
protein ratios approached saturation of the protein binding site, the peaks became 
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broader and distorted. The peak broadening suggests that the formation of 
multiple protein-drug complexes is possible in the presence of increasing 
amounts of the drug. These data may provide some insight into how high 
dosages of the drug affect the structure of Hb.  
         Having demonstrated the formation of adducts between Hb and oxaliplatin 
at 1:1 and 1:10 molar ratios, we further explored the analysis of binding 
interactions involving the formation of Hb-oxaliplatin complexes at higher molar 
ratios (1:50 and 1:100). In contrast to the previous experiment, the effect of 
oxaliplatin was substantially greater than that seen at lower molar ratios. As 
shown in Figure 4c-d, there is a concentration and time-dependent disappearance 
of the protein adducts. Although the CIEF profiles of the two incubation ratios 
appear similar, the degradation kinetic of the adducts exhibit a minor difference 
between the two samples.  According to the CIEF profiles, for higher molar 
ratios (1:100), significant adduct formation is observed after 60 min of 
incubation, at which point changes in the peak shapes and intensities were 
observed (Figs4-3a and 4-4 ). The changes resemble those observed in Figure 
4b. The transformation continues for the first 4 h, before the adducts start to 
disappear rapidly, which suggests that the drug-protein ratios are approaching 
saturation of the protein binding sites.  According to the CIEF profile, when the 
incubation time reached 7 h, the protein adducts vanished completely. This 
phenomenon was also observed for the sample at a 1:50 molar ratio (Fig 4-4c). 
However, significant differences were observed between the two reaction 
mixtures on the kinetics of the drug-protein adduct formation. For example, in 
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the case of the 1:50 molar ratio sample, the altered CIEF profile of the adduct 
was observed after 12 h of incubation (Figure4-4c). Conversely, complete 
transformation of the adducts was observed for the sample with the 1:100 molar 
ratio.  
      It should also be noted that no new peaks were observed in both CIEF 
profiles. The marked effect observed for the higher incubation ratios strongly 
depends on the quantity of the drug in the sample. Therefore, it is not surprising 
that the kinetics of adduct formation was faster for higher incubation ratios. The 
pI values for the two peaks were slightly higher than the control (Fig.4-3).  This 
indicates that as the level of the drugs increases, the adducts may decompose or 
be converted to non-absorbing species, which are no longer visible on the CIEF 
profiles.  
 
4.3.2  Cisplatin- Hb interaction 
     The final phase of the study involved the evaluation of the interaction 
between cisplatin and Hb . The CIEF profiles of Hb-cisplatin, including the two 
pI markers (6.14 and 8.40), is shown in Figures 4-5. Cisplatin transforms to 
positively charged aquated species [(NH3)2PtCl(H2O)]+ 34 11when in contact with 
water. Both these aqua species and the parent drug are responsible for the 
reaction and binding properties of cisplatin.  This agrees with previous 




Figure 4-5.  CIEF electropherograms of human hemoglobin A0 incubated with 
cisplatin for 2 days at 37oC, at (a) 1:1; (b) 1:10; (c) 1:50 and (d) 1:100 molar 
ratios. Separation conditions as given in Section 2.2 ( i.e. cisplatin,  10µmol/L; 
Hb A0 , 0-100 µmol/L; 2% pharmalytes , pH 3-10;0.5% pvp;  pI markers, pI 6.14 
and 8.40; catholyte, 100mM NaOH; anolyte, 100mM H3PO4 ). The observed pI 
variations may rise from small changes of the capillary inner wall properties 
during successive runs. Separation voltage was set to 500 V for 2 min and 3000 
V for the remainder of the time. For peak identification, see Table 4-1. 
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  As has been previously described, the amount of covalent binding 
between Hb and cisplatin increases almost linearly as the incubation period 
increases (Fig4-5). As observed with the previous profiles, the formation of the 
protein adducts begins after 60 minutes of incubation (Fig4-5). Figure 4-5(a-b) 
shows the CIEF profile of cisplatin-Hb interaction at 1:1 and 1:10 molar ratios. 
The peak profiles of the cisplatin-Hb adduct reveal several intriguing differences 
compared to oxaliplatin-Hb at the same molar ratios.  For the Hb-cisplatin 
complex (1:10 molar ratio), adduct degradation was not observed (Fig. 4-5b) 
during the first 48h, whereas the Hb-oxaliplatin complex at the same molar ratio 
vanished after 24h (Fig4-5b). This suggests that cisplatin demonstrates a weaker 
affinity to Hb compared to oxaliplatin, though the formation of the third adduct 
is observed consistently in both CIEF profiles (Fig 4-5(a-b)). The most likely 
explanation is that cisplatin may have other targets of action compared with 
oxaliplatin 45. In contrast, the Hb-oxaliplatin interaction at the same ratio 
produces only two peaks, except at 24 and 48 hrs (Fig4-2a). However, as a 
result, the intensities of these peaks are relatively weak. Similar differences were 




Figure 4-6. CIEF  of Hb ( 1:100 ratios) incubated with oxaliplatin  for 0 and 60 
minutes at 37oC.  The profiles displayed change of the peak area after 60 




Figure 4c-d illustrates the CIEF profiles for the higher reaction mixtures (1: 50 
and 1:100). The profiles in Fig. 4-5 further confirm the formation and 
transformation of adducts between cisplatin-Hb as the concentration of the drug 
increases.  
Table 4-1. Experimental values of the pI shifts of Hb after Hb-oxaliplatin 
adducts formation. 
 





   Peak1 Peak2 
Hb-Oxaliplatin 1:10 0  7.07 7.19 
 0.5 7.10 7.20 
 4  7.13 7.25 
 12  7.18 7.28 
    
1 :50 0  7.02 7.12 
 1 7.05 7.16 
 3  7.13 7.23 
 12 7.10 7.21 
    
    
1:100 0  7.07 7.19 
 1 7.12 7.25 
 4  7.32 7.41 
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Figure 4-7.  CIEF profile of Hb from cancer patients ( lung and colorectal ) 
undergoing oxaliplatin and cisplatin treatment : (a) from healthy volunteers; (b) 
colorectal; (c) lung cancer. 
 
4.3.3 Cisplatin and oxaliplatin – adducts in Erythrocytes of Cancer 
Patiens undergoing oxaliplatin and cisplatin treatment 
We further investigated the formation of Hb  with  oxaliplatin  
and cisplatin adducts by analyzing erythrocyte samples from cancer patients 
and from healthy volunteers. Figure 4-7 is a typical CIEF profile of erythrocyte 
samples from a healthy volunteer (Fig4-7a) and from a patient obtained 1h 
(Fig4-7c) and 48h (Fig4-7b) after infusion of oxaliplatin and cisplatin. The 
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most comprehensive studies regarding the biotransformation of oxaliplatin and 
disposition in cancer patients were conducted in multiple matrices is reported 
by several researchers 2. CIEF analysis of the erythrocyte sample from a 
healthy volunteered showed only the intact Hb and no adducts with the two 
drugs.   Erythrocyte samples from the patients undergoing oxaliplatin and 
cisplatin treatment clearly showed the Hb-adducts. Figure 4-7 shows that at a 
clinical relevant concentration formed three major complexes ( one major and 
two minors) after 1 and 48h of the drugs infusion , whereas erythrocyte from 
healthy volunteered shows only two  peaks.   These two peaks which are 
typical peaks of human hemoglobin (Fig 4-7a) have a pI  6.9. Other minor 
peaks also observed in the same profile, which are representing the isomers of 
human hemoglobin A0 which consist of five isomers in total.  Similar result 
were obtained when oxaliplatin  
( 0.05-0.5µM) and cisplatin were incubated with  a fixed protein concentration  
5.0 x 10-5M Hb for variety of incubation times (Fig 4-5(a-d)). As it can be 
observed, with the increase of oxaliplatin and cisplatin concentration, the 
amount of Hb-drug complexes increases (Fig4-5). In the present work, the 
results obtained agreed with the our previous work , which allows the 
implementation of this methodology as a simple and a robust method for 
characterization of the protein-drug interaction, which is of a great importance 
in the development process of new drug. From the results obtained it can be 
deduced that oxaliplatin and cisplatin show great affinity toward Hb .By 
comparing the binding properties of drugs to Hb 46 and HSA ( chapter 5), it was 
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concluded that both proteins are responsible for the binding of drugs.  
4.4 Conclusion 
  Measurement of the interaction between a drug and a protein by CIEF-
WCID is a simple and reliable technique. The interaction of Hb with oxaliplatin 
and cisplatin has been successfully determined using CIEF-WCID with a 
relatively simple system. It should be noted that the proposed technique only 
allows separation of Hb-drug adducts and a determination of the pI shift of the 
protein. The method can be considered as a complementary rather than a 
competitive technique, because the method exhibits specific ranges of 
applicability, advantages and disadvantages. For instance, with nano-ESI-
MS/MS, the dissociation constant and binding sites may be determined, while 
with CIEF only adduct formations and pI shifts are observed. 
      On the basis of the CIEF profiles of Hb –cisplatin and Hb-oxaliplatin  
produced in this study, there are significant differences in binding patterns 
between oxaliplatin and cisplatin with Hb, presumably due to the differences in 
reaction species and reaction targets.  From the results presented herein, we 
deduce that oxaliplatin shows a greater affinity towards Hb, while cisplatin binds 
less strongly. For both drugs, incubation with Hb for longer durations and at 
higher drug concentrations results in higher levels of adduct formation and 
destabilization of the Hb structure.  Furthermore, a pI shift is observed only with 
the oxaliplatin-Hb   CIEF profiles (Table 1). These experiments confirm the 
validity of CIEF as a simple and convenient method for investigation of protein-
drug interactions. 
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 In addition, blood samples collected from colorectal and lung cancer 
patients were characterized and compared with the sample from healthy 
volunteers by using CIEF method. From the observed results, it is concluded that 
this method is a valid method of determining the binding characteristics of drug 
to protein in vivo and in vitro and the method provided a fast and simple 
technique for the study of drug-protein interaction. Furthermore, it has been 
shown , the presented  method  can be used to study binding of drugs to proteins 

















HUMAN SERUM ALBUMIN INTERACTION WITH OXALIPLATIN 
STUDIED BY SPECTROSCOPIC METHOD AND CAPILLARY 




  Capillary isoelectric focusing (CIEF) provides high resolution separation 
of amphoteric biomolecular species based on differences of their isoelectric 
point in a pH gradient formed by carrier ampholytes when an electric potential 
is applied 1 . This high-throughput technique offers greater resolving power and 
has become a standard method for analysis of protein and protein-ligand 
interaction. The utilization of the whole column detection approach with UV 
WCID gives this separation technique a unique advantage over the conventional 
single point detection 1-4. For example, in single point detection, several 
problems are encountered during the sample mobilization process, including 
protein precipitation, long analysis time and distortion of pH gradient. In 
contrast, CIEF-WCID successfully eliminates the mobilization process by using 
the WCID technique.  
 Thanks to the advantage of on-column detection and the capability of 
attaining real-time monitoring of the changes in peak area, CIEF-WCID is 
suitable for protein-protein and protein-drug interactions. Recently, CIEF-
WCID has been successfully applied in our group to investigate protein-DNA 5, 
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protein-amino acid 6 and protein-lipid 3, 7-9 interactions. Furthermore, we 
demonstrated the use of this technique to determine the molecular weight of 
unknown proteins 10. CIEF-WCID is expected to make a unique contribution in 
proteomic research because of its ability to resolve wide ranges of proteins and 
protein complexes that have small differences in pI in real-time. This technique 
is very important when one studies protein-ligand interactions such as protein-
protein, protein-DNA and protein-drug. 
 The development of efficient and sensitive analytical methods for the 
separation, identification and quantification of drug-protein adducts is 
paramount for understanding the drug activity and toxicity. The objective of the 
present study is to develop a CIEF-WCID to investigate the interactions of 
platinum-containing anticancer drugs, namely oxaliplatin, with a model blood 
protein, human serum albumin (HSA). The structural changes of HSA are 
investigated by monitoring the pI during the incubation of oxaliplatin with 
HSA. CIEF is the highest efficiency, single-dimensional separation method 
available for the investigation of the interaction between proteins and ligands. 
This technique offers a number of advantages, including speed, high separation 
efficiency, short analysis time and reduced sample consumption. Although the 
CIEF technique shows a number of advantages, quantitative information was 
chiefly provided by other techniques. 
  To our knowledge, the investigation of oxaliplatin interaction with HSA 
by CIEF with WCID is the first report of this type of analysis. The development 
of a simple and reliable method to study drug-protein interactions is of great 
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practical and theoretical importance.  
     Platinum-based drugs are among the most active anticancer agents and have 
been widely used in the treatment of a variety of human tumours. Over the last 
30 years, a large number of platinum analogues have been synthesized to 
enlarge the spectrum of activity, overcome cellular resistance and/or reduce the 
toxicity of both first (i.e. cisplatin) and second generation (i.e. carboplatin) 
platinum drugs 11. Of these platinum-based compounds, oxaliplatin, a novel 
compound containing a trans-1-(R,R)-1,2-diaminocyclohexane (DACH) carrier 
ligand, has recently been approved for the treatment of metastatic colorectal 
carcinoma in conjunction with fluoropyrimidines 12. Oxaliplatin has shown in 
vitro and in vivo efficacy against many tumor cell lines and tumours, including 
those that are resistant to cisplatin and carboplatin 11, 13-15. In addition to its 
positive effects oxaliplatin also shows several toxic effects. The main 
cumulative dose-limiting toxicity of oxaliplatin is progressive peripheral 
sensory neuropathy 16, 17. It is also associated with an acute mild neuropathy, 
which reverses in several hours or days 16, 17. Oxaliplatin can also produce 
diarrhea, vomiting and haematological suppression17-19. However, the 
mechanisms of action and toxicity are not clear. 
 Platinum-containing anticancer drugs are believed to induce apoptosis in 
cancer cells by covalently binding to DNA 20-22, however, they also react with a 
number of proteins and peptides, such as glutathione, which may also play a 
role in detoxification of oxaliplatin 23. In addition, after these drugs are 
introduced intravenously, 65 – 98% of the drugs are bound to blood plasma 
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proteins 24-26, and 40% of the blood platinum is found in erythrocytes 26, 27. 
While it is widely accepted that platinum-DNA adducts are responsible for the 
drug’s cytotoxicity, the role of platinum-protein adducts in the mechanism of 
action and toxicity of the drug remains unclear. Platinum-protein adducts are 
suggested to be the cause of the drug’s side effects; however, there are also 
claims that they are important to the drug’s activity 28. Therefore, information 
on how anticancer drugs interact with proteins is important for the 
understanding of the mechanisms of action and toxicity of a drug and the 
optimization of cancer treatments.  
  HSA is an abundant protein that binds a variety of ligands with a typical 
concentration of 35-45 g/L. HSA interferes with certain antitumour drugs, 
changing their biological activity and affecting clinical activity 29. In plasma, 
this protein is responsible for distributing and metabolizing many endogenous 
and exogenous ligands such as fatty acids, bilirubin, colic acid, metal ions, 
steroid hormones and pharmaceuticals, including metallodrugs 20, 24, 29-38. HSA 
contains 585 amino acids and has a molecular weight of 66,500 Da. The crystal 
structure shows ligand binding sights located in the hydrophobic binding 
pockets in subdomains IIA and IIIA, each of which contains two subdomains 
(IA, IB, etc) and is stabilized by 17 disulfide bridges and one free thiol at 
 Cys-34 39. HSA contains a single tryptophan (Trp) residue in position 214 in 
subdomain IIA. At physiological pH (7.4), HSA presents two structural isomers: 
N and B. Ligand binding one of the domains (II or III) induces conformational 
changes on the other domain since both domains share a common interface. At 
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pH 7.4, HSA tends to interact with positive species due to negatively surface 
charge 40. The molecular interaction between HSA with platinum-based 
anticancer agents have been extensively studied by variety of analytical and 
spectroscopic techniques 29-32, 34, 36, 41, 42.  
     In recent work, we investigated the effect of cisplatin and oxaliplatin on 




     Oxaliplatin (99.9%), carrier ampholytes (Pharmalytes 3.0-10.0) and HSA 
were purchased from Sigma (St. Louis, MO, USA). Polyvinylpyrrolidone (pvp) 
was purchased from Aldrich (Milwaukee, WI, USA). Water was purified with a 
NANOpure water system (Barnstead/Thermolyne, Dubuque, IA, USA) and had 
a minimum resistivity of 18.0 MΩ-cm. All of the chemicals employed in this 
study were of analytical reagent and used without further purification. 
 
5.2.2 Solutions and sample preparation 
       Stock solutions of oxaliplatin (trans-1-(R,R)-1,2 
diaminocyclohexane(DACH) oxalatoplatinum) were prepared to a concentration 
of 5 mmol/L. The HSA stock solution was prepared to a concentration of        
25 μmol/L. The stock solutions were freshly prepared everyday. All reaction 
mixtures were prepared in duplicate. 
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5.2.3 Incubation of HSA with oxaliplatin  
      Samples containing a physiological concentration of HSA (5.0 x 10-5mol/L), 
tryptophan (5.0 x 10-5 mol/L) and different concentrations of oxaliplatin 
 (0-100 µmol/L) were incubated at 37oC in a phosphate buffer solution (0.1 M 
pH 7.4) containing 10 mol/L NaCl for a maximum of three days. The pH 
values of all of the reaction mixtures were maintained at 7.4 to mimic 
physiological conditions. The molar ratios of the incubated protein:drug 
solutions were 1:1, 1:10, 1:50 and 1:100, respectively. Aliquots were taken for 
analysis after 0, 0.5, 1, 2, 6, 12, 24, 48 and 72 h. 
5.2.4 Preparation of metal colloid 
The colloid  solutions used in this study were prepared according to the 
description of Lee and Miesel 44. The silver solution was prepared by the 
standard citrate reduction by dissolving 90mg ( AgNO3) in 500mL of H2O and 
brought to boiling. A solution of 1% sodium citrate (10mL) was added. The 
solutions then diluted with water in the ratio of 1:7. The absorption spectrum of 
this brownish solution has a maximum at 500nm ( Fig 5-9). This colloidal 
suspension was stable for several weeks and was stored in the dark. 
5.2.5 Characterization of silver colloids  
 
 AFM images were obtained by measurement of the force on a sharp tip 
created by the proximity  to the surface of the sample45. This force is kept small 
and at a constant level with a feedback mechanism. When the tip is moved 
sideways it will follow the surface morphology. 
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 AFM of colloid images were performed by Jin Xu at the Department of 





Figure 5-1. Atomic force microscopy (AFM) topographic and lateral force 
images of the silver nanoparticles. 
 
5.2.6 CIEF System 
     The CIEF experiments were pursued with a commercial iCE280 instrument 
(Convergent Bioscience, Mississauga, ON, Canada). The system was equipped 
with a charge couple device (CCD) camera for image collection. Separations 
were performed on commercial cartridges with silica capillary tubes 
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(Convergent Bioscience), with an effective length of 5 cm, 100 µm i.d. and 200 
µm o.d. The capillary wall was coated with fluorocarbon (Restek, Bellefonte, 
PA, USA) to suppress the electroosmotic flow (EOF). Focusing was carried out 
for 2 min at 500V and the system was set at 3000V for the remainder of the 
analysis. The catholyte and anolyte contained 1% pvp with 100 mM NaOH and 
100 mM of H3PO4, respectively. The sample, which was mixed with 0.5% pvp 
and 2% ampholyte (pH 3-10), was manually injected with a needle. To avoid 
inconsistent coating efficiency, all capillaries were dynamically coated with 
additives for 30 minutes prior to the experiment. During the focusing process, 
the current was decreased from 10.8 µamp to 4.7 µamp, prior to completion.  
 
5.2.7 UV/Vis absorption measurement 
 UV-Vis spectra were recorded on Ultrospec 2100 Pro UV-Visible 
spectrometer in a 1 cm cuvette. Freshly prepared HSA and oxaliplatin solutions 
were mixed in 1:n ratios (n is integer, varies from 1 to 100). The tryptophan 
solution (5.0 x 10-5 mol L-1) was prepared in pH 7.40 phosphate buffer. The 
UV-Vis spectra were scanned in the range of 200–600 nm. 
 
5.2.8 Fluorescence quenching measurement 
The fluorescence emission spectra of HSA in the presence of oxaliplatin 
were recorded on a PTI QuantaMaster Instrument equipped with a xenon lamp 
source and 1.0 cm quartz cell with a thermostat bath. Fluorescence quenching 
spectra were collected by recording the fluorescence emission wavelength from 
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300 to 500 nm at an excitation wavelength of 390 nm, and with the slit width 
5.0 nm. Freshly prepared HSA and oxaliplatin solutions were mixed in 1: n 
ratios as previously described above.  
 
5.3 Results and Discussion 
 
5.3.1 CIEF Investigation of Oxaliplatin- HSA Interaction 
     We have developed a CIEF technique to investigate the adduct formation 
between HSA and oxaliplatin in aqueous media, mimicking physiological 
conditions. The standard CIEF profile of HSA showed one peak (Fig5-1). The 
focusing time took 8 min. Within the 8 min focusing time, no peak distortion or 
intensity changes were observed. However, the peak area gradually started 
changing with a minor increase of the incubation ratio, and with higher 
oxaliplatin concentrations, the peaks altered drastically and diminished, which 
indicates the adduct formation between the two analytes. Figs 5-1 and 5-2 show 
typical CIEF separation profiles for HSA (control) and HSA-oxaliplatin adducts 
in buffer solution. This result is in excellent agreement with previous 
hemoglobin-oxaliplatin studies, which demonstrated that oxaliplatin induces 






Figure 5-2. The CIEF analysis of HSA (10µmol L-1) incubated for 72 hr at 
37oC. For the CIEF analysis, a sample solution (400 µL) containing 2% 
pharmalytes (pH 3.0-10.0), pI markers (pI 6.14 and 8.40) and 0.5% PVP was 
injected into the capillary by pressure using a syringe. The catholyte and anolyte 
were 100 mmol L-1 NaOH and H3PO4 consecutively. The focusing voltage was 
set at 500 V for 2 min and 3000 V for the remainder of the focusing period. The 
observed pI variations may arise from small changes of the capillary inner wall 
properties during successive runs. 
 
Fig5-2 illustrates drug-free HSA (control) separated by CIEF containing 
two pI markers (4.65 and 7.05). It should be mentioned that the two pI markers 
were used to observe possible pI shifts during the incubation progress. In the 
absence of the drug, the electropherogram of HSA contains only one distinct 
peak, which is characteristic of this protein. The pI value of HSA is 
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approximately 5.7. However, a minor fluctuation can be observed due to an 
inconsistency in the manufacturing of the separation cartridges and focusing 
time. As shown in Fig 5-3a, no significant change was observed for the first 6 hr 
of the incubation period. However, as the incubation time progressed from 6 to 
12 hr, the peak intensity started to decrease accompanying on increase in peak 
width of the profile. A small pI shift is also observed in going from a 12 to 72 hr 
incubation time; this is most likely due to the early stage of adduct formation 
between the two analytes, accompanying the alteration of HSA surface 
properties.  
The CIEF profile for the reaction mixtures that contain HSA-oxaliplatin 
(1:1, 1:10, 1:50 and 1:100 molar ratios), is shown in Fig 5-3(a-d). From          
Fig 5-3a, it is seen that as the incubation ratio reached 12 hr, the area of the 
CIEF profile of HSA increased, which indicates the stage at which the adducts 
start forming between the two analytes. However, the profile indicates no pI 
shift or structural change within the 72 hr incubation time. This indicates that 
the structural change was less evident at low drug concentration. From Fig5-2a, 
we also observed that the CIEF profiles are identical to that obtained in Fig5-1. 
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Figure 5-3. Electropherograms representative of binding of HSA with 
oxaliplatin: (a) 1:1 ; (b) 1:10 ; (c) 1:50 and (d) 1:100 molar ratios. The drug-
protein mixtures were incubated for 3 days at 37oC. Appropriate amounts of the 
incubated samples were removed and mixed with 0.5% pvp, 2% pharmalytes 
(pH 3.0-10.0) and pI markers (4.65, 7.05, 8.40 and 9.77) for each CIEF run. 
Catholyte and anolyte were 100 mM NaOH and H3PO4. On electropherogram c 
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and d, the pI markers were not mixed with the running sample due the formation 
of fragments after 24 and 48hr incubation time. For all solutions, the total 
concentration of HSA was constant: 5.0 x10-5mol L-1.The separation conditions 
are described in Fig 5-1.  
Figure 5-3(b-d) shows the CIEF profile of HSA-oxaliplatin adducts in 
1:1, 1:10, 1:50 and 1:100 molar ratios, incubated at 370C under the same CIEF 
conditions. The spectral profile of Figure5-2b (1:10 molar ratio) shows the 
protein was markedly affected by the complexation with oxaliplatin. For short 
incubation times (0 to 6 h), in contrast to Fig5-1 and Fig5-2a, a minor pI shift 
was observed after 1 hr of incubation. Also shown in Fig. 2b is the increase of 
spectral width. When the incubation time progressed from 1 to 72 hr, the 
relative intensity of the peaks was decreasing as a function of incubation time. 
Although the pI shift was not significantly changed between the time frame of 
12 to 72 hrs, the drug induced structural alteration of the protein structure. This 
demonstrates the stage at which the adducts are formed between the two 
analytes. The decreasing intensity and increasing area of the CIEF profiles 
further demonstrate the effect of the drug on the protein structure. The pattern of 
the electropherograms recorded for samples containing 1:50 and 1:100 molar 
ratio of HSA-oxaliplatin showed substantial differences from the other samples 
(1:1 and 1:10 molar ratio). As shown in Fig5-2(c-d), there is a concentration and 
time-dependent CIEF profile alteration and structural breaking down into 
fragments, or forming aggregates of the protein adducts. Although similar CIEF 
profiles were observed for the two incubation ratios, the degradation kinetics 
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show a minor difference between the two samples. In the case of Fig 5- 1c 
(1:50), the distortion of the protein adducts started after 6 hr of incubation time, 
followed by peak shape changes. These are the expected results since the 
sample contains a smaller amount of oxaliplatin compared to that of the 1:100 
ratio. It can also be seen that the CIEF profile exhibits pI shift, suggesting that 
adducts form between the two analytes. As time progressed, the adducts formed 
completely dissociated after 12 h of incubation time, which suggests that the 
drug-protein ratios are approaching saturation of the protein binding sites. 
Previously, we had shown that there is a biologically significant interaction 
between protein (Hb A) and oxaliplatin 40. Similar behavior was observed when 
oxaliplatin incubated with Hb at the two ratios (1:50 and 1:100). However, for 
1:100 molar ratio, the dissociation of the adducts starts after 6 hr, which 
suggested that the kinetic transformation was faster compared with the lower 
molar ratio, (1:50) . These two samples show very different behavior under the 
same separation conditions. One of the significant differences between the two 
samples was the relatively broader peak shape for the 1:100 molar ratios. This 
broader peak starts appearing after approximately 1 h of incubation time. When 
the incubation time reached 12 hr, the peak almost disappeared and the 
fragments of the adducts appeared. One possible explanation was that the 
formed adduct was breaking down or changing to other species as incubation 
time progressed. It has been shown in a number of previous studies that HSA 
contains platination sites such as Met, His, or S-S bonds 34. Since the S-S bridge 
is responsible for the stabilization of HSA, a high concentration of oxaliplatin 
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might cleave the S-S bridge. This may lead to the activation of  the protein 
aggregate, which was observed in our experiments for the two higher incubation 
ratios (1:50 and 1:100).   
 
5.3.2 UV/Vis spectra of HSA and HSA-oxaliplatin adducts 
For reconfirming the structural changes of HSA upon complexation with 
oxaliplatin, the UV/Vis absorption spectra of HSA with various amount of 
oxaliplatin were collected. Similar to the previous investigations using CIEF-
WCID, samples with 1:1, 1:10, 1:50 and 1:100 molar ratios were incubated for 
1 hr at 370C in a water bath. In parallel with HSA-oxaliplatin incubated 
mixtures, blank samples of HSA, oxaliplatin and tryptophan were investigated 
by similar techniques as a control. The two controls (HSA and oxaliplatin) 
demonstrate the maximum absorption at 278 and 255 nm. Thus, by comparing 
the peak intensities and the optical absorption with HSA-oxaliplatin adduct, the 





Figure 5-4. The absorption spectra of HSA and tryptophan in the presence of 
oxaliplatin incubated in phosphate buffer at room temperature. For all solutions, 
the total concentration of HSA was constant: 5.0 x10-5mol L-1  (a) HSA-
oxaliplatin molar ratios at 0:1, 1:0, 1:1, 1:10 , 1:50 and 1:100 incubated molar 
ratios; (b) Tryptophan- oxaliplatin mixtures were (curves  12 to 1): 1:0, 1:1, 1:2 













































Figure 5-5. The UV/Vis spectra of HSA-oxaliplatin in (a) 1:1, (b) 1:10, (c) 1:50 
and (d) 1:100 molar ratio and the reaction mixtures incubated for 0, 1, 6, 12 and 
24hours at 370C in water bath. The incubated buffer contained 5.0 x10-5M HSA 
with oxaliplatin concentration varied from 5.0 x 10-5 to 5.0 x 10-3mol/L. 
 
 Fig 5-4 demonstrates the optical absorption spectra of HSA-oxaliplatin 
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(1:1), which is a fairly close approximation to the real drug-protein proportions 
in blood, the drug effect was minimal. Fig5-4a shows the absorption spectrum 
of HSA incubated with oxaliplatin in a 1:1 molar ratio. The absorption spectra 
show no significant changes for this incubation ratio. However, the peak shape 
and intensity start to change upon increase of the drug concentration (1:10 
molar ratio). This effect shows the beginning of the formation of adducts 
between the two analytes. Although the peak intensity was not significantly 
changed for 1:10 molar ratio for the first 24 h period, multiple peaks appeared 
as the incubation time progressed to 48 h. This result suggests that multiple 
forms of the adducts formed due to different conformations of the protein. It is 
also possible that the formed adducts are degraded after a higher incubation 
time was reached. These surprising results were also observed in higher 
incubation ratios of the CIEF-WCID studies. Having demonstrated the 
formation of adducts between HSA and oxaliplatin at 1:1 and 1:10 molar ratios, 
we further explored the analysis of binding interactions involved in the 
formation of HSA-oxaliplatin complexes at higher molar ratios (1:50 and 
1:100). In contrast to the previous experiments, the effect of oxaliplatin was 
substantially greater than that seen at lower molar ratios. As shown in Fig5-4(b-
c), for higher drug concentrations, the kinetic formation of adducts was faster 
for 1:100 molar ratios. This can be attributed to a very high drug concentration 
present in reaction solutions. It is important to note that such high drug to 
protein ratios were used to ensure the complete (equilibrium) binding. In 
addition, for the high incubation ratios (1:50 and 1:100), the amount of adducts 
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formed increased as the concentration of the drug increased, accompanied by 
baseline changes.  
 
5.3.3 Fluorescence quenching spectra and quenching mechanism 
Fluorescence quenching can be described by the Stern-Volmer equation 46: 
 




SV+=+= τ                                                     (1) 
 
Where F0 and F are the fluorescence intensities in the absence and presence of 
the quencher, Kq represents the quenching rate constant, KSV the Stern-Volmer 
dynamic quenching constant,     τ0(10-8s) 47 the average lifetime of the 
biomolecule without quencher, and [Q] is the concentration of the quencher 
respectively. The Ksv and Kq values are calculated from the linear plot of F0/F 






K =                                                                                               (2) 
 
 
There are two kinds of fluorescence quenching: dynamic and static. 
These two mechanisms can be distinguished from each other by their differing 
dependences on temperature and excited-state life time. The Ksv value decreases 
with an increase in temperature for static quenching, but there is a reverse effect 
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on dynamic quenching. For higher temperatures, the diffusion constant 
increases, due to the dissociation of weakly bonded complexes. It is well known 
that the maximum scattering collision quenching constant of various quenchers 
with biological macromolecules is about  2.0 x 1010 l mol-1s-1 . For HSA-
oxaliplatin as shown in Table 1, the quenching constant is much higher than 2.0 
x 1010l mol-1 s-1. The Ksv decrease with temperature increased. Therefore, it can 
be concluded that the quenching was not initiated by dynamic collision but 
probably initiated by static quenching resulting from complex formation 
between HSA-oxaliplatin.The intrinsic fluorescence of HSA is essentially due 
to tryptophan alone, because phenylalanine has a very low quantum yield and 
the fluorescence of tyrosine is almost totally quenched if it is ionized or is near 
an amino group, a carboxyl group, or a tryptophan residue. 
 
Figure 5-6. Fluorescence spectra of HSA (5.0 x 10-5 mol L-1) in the present of 
oxaliplatin (5.0 x 10-5 mol L-1) at 470C; curves (1-14), 0, 




Figures 5-5 and 5-6 show the fluorescence emission spectra for HSA 
with various molar ratios of oxaliplatin at pH 7.4, excited at 290 nm. As the data 
shows, the fluorescence spectra of HSA progressively decreased with the 
increasing concentration of oxaliplatin. These observations can be rationalized 
in terms of interactions between oxaliplatin and HSA and formation of 
complexes between the two analytes. 
 
Figure 5-7. Fluorescence spectra of HSA (5.0 x 10-5mol L-1): oxaliplatin (5.0 x 
10-5mol L-1) : curves (1-14), 0, 1.0,2.0,4.0,6.0,8.0,10.0,12.0,14.0.16.0, 




Figure 5-8. Stern-Volmer plot for the binding of HSA-oxaliplatin at different 
temperatures (298, 310 and 320K). 
 
Table 5-1 
Stern-Volmer dynamic quenching constants and quenching rate constant of 
HSA and oxaliplatin at different temperatures 
pH T(K) KSV/l mol-1 Kq/l mol-1 S-1 R 
7.40 298 1.480 X 103 
 
1.480 X 1011 0.997 
7.40 310 1.120 X 103 1.120 X 1011 0.993 










5.3.4 Influence of Silver Colloid on Protein’s pI 
 
 Silver nanoparticles can be rapidly produced by a strong 
reducing agents, such as borohydrate or sodium citrate. There is a long 
nucleation period, resulting in particles of varying sizes48. For example, the 
commonly used citrate reduction method44, produces a distribution of 
particles different sizes and shapes. Silver colloid is commonly used for 
surface enhanced Raman spectroscopy (SERS). However, here our primary 
goals was to demonstrate , by comparison of CIEF profiles of the a protein, 
that the silver colloid affect the pI of the protein when it incubated for the 
period of 8 hrs.   
 
The interaction occurs through hydrophobic and electrostatic 
interactions of silver particles and protein.  Our experiments have shown 
that the protein structure is preserved upon adsorption to the metal surface 
and there no possibilities for changes after the adsorption took place. 
Fig 5-9 shows the CIEF spectrum of Carbonic Anhydrase I incubated 
with silver colloid.   The electropherogram shows the cIEF profile of 
Carbonic Anhydrase I incubated  with Ag colloid solution. Two major 
properties are  expected when protein absorb onto colloidal particles; the 
proteins may either stablized or destablized the colloidal dispersion or  they 
may affect the charge distribution of the nanoparticles.  This protein 
contains a positive charge so no interaction was expected when mixed with 
a Ag colloid. However, the pI was shited to left with a short incubation 
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period. This shows that the positive charge from the Ag colloid, enhance 
the positive charge on the protein to cause a shift to the left. However, the 
reasons of the distortion of the protein structure not clear.   
 
The amount of intially added colloid slightly influenced the stability of the 
protein. 
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Figure 5-9. The observed pI shift of Carbonic Anhydrase I upon incubated 
with Ag colloid for a short period of time. 0.3mg/mL of carbonic 
Anhydrase I mixed with 10, 20 and 30µL of citrate colloid ( 5.00 x 10-3M) 






Figure 5-10. The Ag solutions which are prepared by the Lee procedures. 
The greenish yellow solution is prepared by citrate reduction procedures. 
This solution shows a strong SERS activity( Fig5-9). However, the second 

















































CIEF-WCID allows us to monitor the pI shift and structural alteration of 
the protein, when interacted with ligands such as the anticancer agents 
(oxaliplatin). Several conclusions can be drawn from the results presented here. 
First, the experimental results demonstrate the significant effects of oxaliplatin 
on the structural stability of HSA when incubated for a maximum 72 h at 
physiological pH. Second, on the basis of the data presented here, it may be 
hypothesized that oxaliplatin may have multiple binding sights on HSA, and, at 
higher molar ratios, oxaliplatin may cleave S-S the bond, which is responsible 
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for the stability of the protein. Previous work suggested that cisplatin, the same 
platinum-based anticancer drug, interacts with multiple sights on HSA when 
incubated with the protein 42. Furthermore, quenching of the intrinsic 
fluorescence of HSA reinforces the formation of the HSA-oxaliplatin complex. 
The red shift of the absorption peak of HSA and tryptophan indicates the strong 
effect caused by oxaliplatin and complex formation of the two analytes.  
Finally, CIEF-WCID can help to elucidate the anti-cancer mode of 
action regarding the affinity toward proteins. However, the technique can be 
considered as a complementary rather than a competitive technique, because the 
method exhibits specific ranges of applicability, advantages and disadvantages. 
For instance, with nano-ESI-MS/MS, the dissociation constant and binding sites 
















CAPILLARY ISOELECTRIC FOCUSING COUPLED WITH DYNAMIC 
IMAGING DETECTION: A ONE-DIMENSIONAL SEPARATION FOR 





      Isoelectric point (pI) and molecular weight are two primary attributes for 
protein characterization and analysis. Classical two-dimensional gel 
electrophoresis (2D-GE) combines isoelectric focusing (IEF) and sodium 
dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE). Although it 
offers outstanding high resolution, this method is time-consuming (unusually 
more than 10 h) and lacks automation. Attempts have been made to overcome 
the shortcomings of 2D-GE, including combining IEF in capillary-format 
(CIEF) with electrospray ionization (ESI)-mass spectrometry (MS)1-3 and 
replacing SDS-PAGE with matrix-assisted laser desorption/ ionization 
(MALDI)-MS4, 5.  
 
*The result presented in this chapter have been published: 
Zhen Liu, Tibebe Lemma, and Janusz Pawliszyn, 
Capillary Isoelectric Focusing Coupled with Dynamic Imaging Detection: A 
One-Dimensional Separation for Two-Dimensional Protein Characterization, 
Journal of Proteome Research 2006, 5, 1246-1251 
The candidate equally contributed to this work. 
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Clearly, these methods require two one-dimensional separations or two one-
dimensional instruments. So far, there is no single one-dimensional 
separation/instrument that can determine both pI and molecular mass. In this 
study, we present a simple but capable approach to achieve 2D characterization 
and analysis of proteins employing a single one-dimensional separation. 
Proteins were first focused into stationary bands by CIEF in a short column (5 
cm long). The focusing process in the whole column was dynamically imaged 
by a CCD camera through detecting UV absorbance , a technique that is 
referred to as whole-column imaging detection (WCID)6-13. The pI values are 
calculated from the peak positions through comparing with a calibration curve 
built with standard pI markers. After completion of the focusing, the applied 
voltage is turned off, and thus, the focused protein bands are allowed to diffuse, 
resulting in band broadening. The dynamic diffusion process is monitored by 
the CCD camera. Diffusion coefficient (D) is determined according to the 
Einstein equation14 
                                                          σ2 = 2Dt                                        ( 1 ) 
 
 where σ2  is the spatial peak variance due to diffusion, and t is the diffusion 
time. When σ2 is plotted against the separation time, a linear relationship can be 
obtained, the slope of which equals 2D. Furthermore, there is a general formula 
that allows acceptable estimation of molecular weight from diffusion 
coefficient,15-17 
                                                           D= A (T, η)M-1/3                         ( 2 ) 
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 where A is a function of temperature (T) and the viscosity of the medium (η), 
and M is the molecular mass. When T and η  are kept constant, the linear 
relationship between M-1/3 and D can be used as a calibration curve for 
determining molecular weight. The principle of the 2D protein characterization 
approach is illustrated in Figure 6-1. Recently, CIEF-WCID has developed as a 
reliable pI-based protein characterization and analysis tool9, 10. It offers a 
baseline resolution of 0.03 pH units, comparable to carrier ampholytes-based in-
gel IEF (0.02 pH units). It provides better reproducibility as compared with in 
gel IEF, with a SD of 0.01 pH units (corresponds to an RSD of 0.2%) for pI 
determination and an RSD of 4% for quantitation. As the use of CIEF-WCID 
for pI determination has been described in previous publications,9, 10 this study 
focuses on the measurement of diffusion coefficient and the determination of 
molecular weight from diffusion coefficient. 
The diffusion coefficient of a molecule is important physical property 
that can indicate the size, shape,   and effective charge of an ionic species. If 
diffusion is the only source of band broadening in the separation capillary, then 
it is possible to measure the diffusion coefficient from an electropherogram. 
Several techniques are available for measurement of diffusion 
coefficients. Techniques for measuring diffusion coefficients include free 
diffusion 18, sedimentation19, quasi-elastic light scattering (QLS)20 and pulse 
NMR techniques 21. 
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   Unlike classical 2D-GE, in which proteins are usually broken into 
polypeptide chains by using denaturing and reducing reagents, the CIEF-WCID 
approach can be a useful tool for studying protein oligomeric state. The 
oligomeric states for β lactoglobulins (A and B), lentil lectin (isoforms I and II), 
glyceraldehyde-3-phosphate dehydrogenase and urease have been well 
documented in literature 22. When these proteins were considered as monomer, a 
significantly degraded correlation between M-1/3 and D for the same set of 
proteins was observed. Therefore, if the diffusion coefficient measured for a 
protein is slower than expected from its molecular weight, it indicates a higher-
order oligomeric state. For example, the diffusion coefficient for cyctochrome C 
from bovine heart was determined to be 1.05 × 10-7 cm2/s and the molecular 
weight was calculated to be 22,900, which is 1.86 times higher than its actual 
molecular weight (12,300). This result implies a dimer form of this protein 
under the CIEF conditions. 
The experiments described above were performed under native 
conditions, under which the native structure and biological activity of the 
protein are maintained. However, the isoelectric precipitation problem (proteins 
tend to precipitate at the pI value under conditions of very low ionic strength) 
under native conditions is severe for some proteins. This problem can be 
overcome by adding either protein denaturing reagents or protein solubilizers 
that are compatible with native structure and maintenance of biological activity. 
Classical 2D-GE often uses denaturing conditions to solubilize proteins in first 
dimensional separation (IEF). The possibility of measuring diffusion coefficient 
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under denaturing conditions was explored. Trypsin inhibitor is a representative 
protein that aggregated severely under native conditions. It exhibited multiple 
irreproducible sharp peaks at high concentration (≥ 0.1 mg/mL) but one single 
reproducible peak at low concentration (< 0.1 mg/mL). After withdrawing the 
focusing voltage, these peaks did not broaden at all. When denaturing 
conditions with addition of 6 M urea were used, the protein exhibited a single 
reproducible peak and its diffusion obeyed the Einstein equation very. 
In the proposed approach, the total resolution is determined the CIEF 
separation (up to 100 peaks), which is much lower than that of a 2D-GE 
separation (up to 10,000 spots). Therefore, it is only suitable for protein samples 
of low to moderate complexity. Two applications are demonstrated in the study. 
One is to quickly identify whether a protein is degraded or not. If a protein is 
degraded, it will diffuse faster.  
  In summary, a technique developed a “two birds with one stone” 
approach for protein characterization/analysis: to measure pI and molecular 
mass simultaneously by using a single one-dimensional instrument. This 
approach benefited from the dynamic detection capability of the WCID 
technique developed in recent years. The accuracy is comparable to that of 2D-
GE. Although the resolution is not as high as that of 2D-GE, this approach has 
several significant advantages. The procedures involved are very simple. The 
speed is very fast, taking only 10-30 min. The approach can be expected to be a 




 6.2.1 Apparatus 
  Experiments were conducted on a commercial iCE280 analyzer 
(Convergent Bioscience, Toronto, Canada) 10. The detection was performed 
using UV-WCID equipped with 280nm excitation source. The separation 
column was fluorocarbon internally coated fused-silica capillary (100 μm ID × 
5 cm) to avoid wall absorption and supported by a cartridge (Convergent 
Bioscience, Toronto, Canada).  
6.2.2 CIEF Method  
The cartridge was conditioned with a 0.5% (w/v) pvp solution for 20 
min before experiments. The protein samples were 0.03-0.3 mg/mL for other 
proteins, containing 2% Pharmalytes (pH 3-10) and 0.5% pvp. The sample was 
injected to fill the whole separation column. The applied voltage was 500 V for 
2 min for UV-WCID and then increased to 3 kV. After a steady focusing was 
reached, the focusing voltage was turned off to let the focused protein diffuse. 
The focusing and diffusion processes were monitored by imaging detection at 
desired times.  
The small molecules were run in  the same capillary as CIEF. However, 
the two tanks ( anode and cathode ) were filled with a 0.05M phosphate buffer, 
pH 7.00. Sample ejection   was by electromigration for 60sec at 1.5kV. The 
analytes concentration in the sample ranges from 1 to 4.7 x10-3M. 
Electrophoresis was carried out at 3 kV.  
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6.2.3 Materials and Chemicals  
Pharmalytes (pH 3-10, 40% in concentration), polyvinylperrolidone 
(PVP, average molecular weight about 360,000 and intrinsic viscosity 80-100 
K), and other proteins were purchased from Sigma (St Louis, MO, USA). The 
anolyte and catholyte were 100 mM phosphoric acid and 100 mM sodium 
hydroxide, respectively. Water was purified with an ultra-pure water system 
(Barnstead/Thermolyne, Dubuque, IA, USA).  
 
6.3 Results and Discussion 
6.3.1 Diffusion coefficient for proteins and peptides 
CIEF is a unique CE mode in which the electric current through the 
capillary exponentially drops along with the separation time, and the residual 
current is quite low at the end of the focusing, for example, less than 5 µA when 
an applied voltage of 3 kV and 2% carrier ampholytes were used. Joule heating 
was further reduced by using low initial focusing voltage (500 V) and 
increasing it to 3 kV as focusing neared completion (maximum current of a run: 
18 µA). It was assumed that if there was a temperature variation, it would be 





Figure 6-1. The principle of the 2D protein characterization approach using 
CIEF-   WCID. (a) CIEF   experiment to measure the peak position in the pH 
gradient;    (b) calibration curve of the pH gradient; (c) dynamically monitoring 
the diffusion of the protein band; (d) measuring the diffusion coefficient by 
plotting σ2 against the separation time (D ) slope/2); (e) calibration curve for 
molecular weight measurement. 
 
     For this experiment, sixteen proteins and peptides with molecular weights 
from 295 to 272 000 were chosen as test proteins (Table 6-1). Diffusion 
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coefficients of these proteins were measured under identical conditions. The 
diffusion coefficient measurement is illustrated in Figure 6-2. The diffusion 
processes of the test proteins and peptides obeyed the Einstein equation very 
well, giving squared correlation coefficients of >0.99 in most cases. Acceptable 
reproducibility was obtained; for instance, the RSD was 2.0% for carbonic 
anhydrase II and 6.7% for myogloblin . Table 6-1 lists the experimental 
diffusion coefficients, along with available literature data for comparison. We 
emphasize that the diffusion coefficients in this study were measured at the pI 
values of the proteins, whereas those in the literature were usually not. As the 
diffusion coefficients of proteins reported in the literature depend on the surface 
charge of the protein molecule, the diffusion coefficients measured at isoelectric 
pH should provide a more reasonable measure for protein diffusivity as 
compared with those measured at other pH conditions, since the protein 
molecules have zero net charge at their isoelectric pH. The effect of charge 
status on the diffusion of bovine serum albumin (BSA) was investigated, as 
shown in Figure 6-3. The diffusion coefficient of BSA was determined to be 
7.44 x10-7 cm2/s at neutral state, while 11.65 x 10-7 and 12.75 x 10-7 cm2/s when 
the protein was positively and negatively charged, respectively. These data 
indicate that electrostatic interactions have a significant effect on diffusion. This 




Figure 6-2. Measurement of diffusion coefficient of protein by CIEF-WCID. 
(a) The electropherograms at different separation times (the focusing was 
terminated at 7 min); (b) the plot of σ2 against separation time. σ2=-6.14 x 10-4 
(±1.16 x 10-5) + 1.84 x 10-6 (±1.95 x 10-8)t, r2 = 0.9995, SD = 4.49 x10-6, n = 7. 
σ  was calculated from the peak width at half peak height (W1/2) according to σ 
= W1/2/2.35. To simplify the data-processing, the separation time instead of the 
diffusion time was used to perform the linear fit, which contributes an intercept 






        Figure 6-3 shows the linear relationship between M-1/3 and D, which gave 
excellent linearity (r2 = 0.9987). The validity of this calibration curve was 
evaluated by the leave-one-out approach (using all but one protein in the data 
set to establish a calibration curve and then using the remaining one to test the 
prediction, and repeating this process until all proteins are tested), and the 
estimated values and errors are also listed in Table 6-1.  
 
 
Figure 6-3. Calibration curve for the molecular weight estimation.  
M-1/3 =5.77 x 10-4 (± 5.67 x 10-4) + 3.30 x104 (± 3.17 x102) D, r2 = 0.9987, 











Figure 6-4. The correlation betweenM-1/3 and D when considering all proteins 
tested as monomers. The use of incorrect oligomeric states led to a degraded 
correlation (refer to Figure 6-3). M-1/3 =5.03 x 10-3 (±1.56 x 10-3) + 3.17 x 104 
(±8.72 x 102)D, r2 = 0.9894, SD = 4.21  x 10-3, n = 16. 
 
The errors were <8.5% for nine proteins, 10-15% for four proteins, and within 
20-26% for the remaining three proteins, giving an average error of 9.9%. Such 
accuracy is comparable to that of 2D-GE (5-20%), for example, an average 








Table 6-1. Experimental Diffusion Coefficients, Estimated Molecular Weights, 
and associated Errors. 
 
Protein/peptide M Oligomeric 
state 
Dexp 












295 monomer 40.60  270 -8.4 
Leucine 
enkephalin 




1046 monomer 29.60 25.2524 1000 0.6 
Myoglobin, 
isoform 1 (pI ) 
7.2), horse heart 
17000 monomer 12.50 11.325 13200 -20.7 
Rypsinogen, 
bovine pancreas 









29250 monomer 9.27  33250 14.0 
β-lactoglobulin 
B,bovine milk 
36550 dimer 8.99 3.1426 36100 -1.1 
β-lactoglobulin 
A,bovine milk 
36800 dimer 8.56 7.3827 42300 14.7 
Albumin, bovin 
serum 
66000 monomer 7.75 5.9025 63500 -4.8 
Lentil lectin, 
isoform      I ( 
pI=8.2) 
98000 dimer 6.56  92400 -7.6 
Lentil lectin 



















240000 monomer 4.81  234800 -7.0 
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Urease,jack bean 272000 trimer 4.56 3.4625 276600 -3.9 
 
It was found that the diffusion coefficient depends on not only the 
molecular weight but also the oligomeric state of proteins. The oligomeric states 
for β lactoglobulins, lentil lectins, glyceraldehyde-3-phosphate dehydrogenase, 
and urease have been well-documented in the literature.19, 28 When these 
proteins were considered as monomers, a significantly degraded correlation 
between M-1/3 and D for the same set of proteins was observed, as seen in Figure 
6-1. If the diffusion coefficient measured for a protein is slower than expected 
from its molecular weight, therefore, a higher-order oligomeric state is 
indicated. For example, the diffusion coefficient for cyctochrome C from bovine 
heart was determined to be 1.05 x 10-7 cm2/s, and the molecular weight was 
calculated to be 22 900, which is 1.86 times higher than its actual molecular 
weight (12 300). This result implies a dimer form of this protein under the CIEF 
conditions. 
  The experiments described above were performed under native 
conditions, where the native structure and biological activity of the protein are 
maintained. However, the isoelectric precipitation problem (proteins tend to 
precipitate at the pI value under conditions of very low ionic strength) under 
native conditions is severe for some proteins. This problem can be overcome by 
adding denaturing reagents such as urea to improve the solubility of protein. 
The possibility of measuring diffusion coefficient under denaturing conditions 
was explored. Trypsin inhibitor is a representative protein that aggregates 
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severely under native conditions. It exhibited multiple irreproducible sharp 
peaks at high concentration (>0.1 mg/mL) but one single reproducible sharp 
peak at low concentration (<0.1mg/mL). After withdrawing the focusing 
voltage, these peaks did not broaden at all. When denaturing conditions with the 
presence of 6 M urea were used, the protein exhibited a single reproducible 
peak and its diffusion obeyed the Einstein equation . In the proposed approach, 
the total resolution is determined by the CIEF separation (up to 100 peaks), 
which is much lower than that of 2D-GE (up to 10 000 spots). Therefore, it is 
only suitable for protein samples of low to moderate complexity. Two 
representative applications are demonstrated in the study. The first one is to 
quickly identify whether a protein is degraded or not. If a protein is degraded, it 
will diffuse faster. The normal protein, which was stored at 2-8 °C, exhibited a 
diffusion coefficient of 4.81 x 10-7 cm2/s.  
 
6.3.2 Diffusion Coefficient of Small Molecules 
To evaluate the feasibility of CIEF as a means of measuring diffusion 
coefficients of proteins, the technique was initially tested on small molecules 
that do not tend to display adsorptive behavior in a separation capillary. The 
samples selected for this initial study were dansyl-alanine, epinephrine, 
fluorescamine, phenol and L-tryptophan ( Table 6-2). 
  In this technique, contrary to the CIEF method, the samples were 
injected by electromigration at 1.5 kV for 5 sec and permitted to migrate 
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approximately halfway to the capillary. The voltage then turned off, and the 
solute is allowed to diffuse for several minutes. 
 
 The results of the above-described experiments are given in Table 6-2. 
These are all measured in 0.05 M phosphate buffer , pH=7.4. The 
experimental D values of the two neurotransmitter (epinephrine and 
dopamine) have been measured by flow injection analysis (FIA) and is not in 
good agreement with the present results (Fig 6-5).   The discrepancy is 
probably caused by the total charge differences on the analytes or the mobility  
difference between the sample and the buffer 28. However, the two amino 
acids ( L-tryptophan and dansyl alanine) showed  only a small differences 
compared with the published values29. Note that most of the tabulated D 
values are normally obtained in water, whereas the results tabulated in Table 
6-2 were measured in phosphate buffer and should posses different charge 
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Figure 6-5.  Measurement of diffusion coefficient using capillary zone 
electrophoresis. (a) The elctropherograms at different separation times; (b) plot 
of peak varience (σ2) against separation time. Separation parameter; 50 mM,  













    6.4 Conclusions 
     The method developed is simple but effective approach for protein 
characterization, measuring pI and molecular mass using a single instrument. 
This approach benefited from the dynamic detection capability of the WCID 
technique. While yielding accuracy comparable to that of 2D-GE, this approach 
has several significant advantages, including speed (10-30 min per run) and ease 
of operation and automation. The approach can be expected to be a useful 2D 
chatacterization/analysis  tool for protein samples of low to moderate 
complexity. When combined with prefractionation techniques, it can be applied 






























A new high performance Raman technique has been developed which 
employs low loss liquid core optical fibers of a short Teflon tube and a small 
probe volume Raman scattering based detector which is compared to 
conventional sample methods.  In the new technique, the focused beam from an 
argon ion laser passes through 50 mm or more of a liquid or solution contained 
in a hollow fused quartz optical fiber having a core diameter of ~120 µm. The 
refractive index of the liquid or solution must be greater than that of the Teflon 
tube  at both the wavelengths of the Raman and exciting radiations. The 
intensified radiation emerging from the optical fiber is simply collected near the 
entrance optics of the Raman spectrometer. The major advantages of the method 
are that very high Raman intensities are obtained and that only very small 
amounts of sample are required  . The new fiber optics laser-Raman method 
should be of use in routine analytical procedures involving a wide range of 
solutions, for example, in the analysis of protein-ligand interactions, of solutions 
of biologically interesting materials, solutions of gases and solids, and involving 
traces pollutants. 
  The early chapters of this thesis were focused on the development and 
characterization of the instrumentation. In chapter 2, the performance and the 
various stages in the design and specifications of LCW-RS were discussed. The 
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performance of the instrument was evaluated using seven acetaminophen based 
Tylenol tablets with minor chemical composition differences. These results are 
important for future work of LCW-RS when it will be coupled to CIEF and 
Solid phase microextraction (SPME) to increase the limit of detection and to 
analyze wide ranges of molecules. 
      In chapter 3 the successful implementation of the liquid-core waveguide 
based Raman spectrometry using a short Teflon tube was demonstrated. Using 
this approach and a 6-nL probe volume, we have measured the Raman signal 
from the physiological concentration of HSA, oxaliplatin , HSA+oxaliplatin  as 
test  compounds. By demonstrating the feasibility of this technique, we have 
taken the first step in realizing the unparalleled collection efficiency of such 
scattering events occurring in the core of a short Teflon tube.  
  In chapter 4, in an attempt to understand how platinum based 
metallocomplexes bind to proteins, two different techniques have been applied 
to characterize the complex formation. Using oxaliplatin and cisplatin as 
reference drugs, the application of CIEF-WCID to reliably assess drug-Hb 
interaction was validated. On the basis of the CIEF profiles of Hb-cisplatin and 
Hb-oxaliplatin obtained using this method, differences in the binding patterns 
were observed for the two drugs. From the results presented in this chapter, 
oxaliplatin shows a greater affinity toward Hb at the physiological concentration 
of the proteins, while cisplatin binds Hb less strongly. However, the 
experiments also show for longer incubation periods and higher concentrations 
of the drugs resulted in the formation of adducts and destabilization of the 
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protein structures. These experiment confirm the validity of CIEF-WCID as a 
valid technique to characterize protein-drug interactions. In future, a variety of 
chemotherapeutic drugs and their interactions with different proteins under 
physiological conditions can be characterized using this simple technique when 
coupled with laser induced fluorescence (LIF). This chapter generalizes the 
validity of the CIEF-WCID technique for the study of protein-drug interactions 
and provides useful information and insight into the interaction of anticancer 
drugs with HSA for further toxicity of these chemotherapeutic drugs and 
improving their clinical performance. 
In Chapter 5 a method  was described to examine the interaction 
between the platinum-based anticancer drug, oxaliplatin, with human serum 
albumin (HSA) in aqueous solution at physiological pH with drug 
concentrations of 10 to 100 µM and a constant concentration of HSA  
(5.0 x 10-5 M). The reaction mixtures were incubated for 0, 0.5, 1, 12, 24, 48 
and 72 h at 370C in a water bath. The CIEF results indicate that with increasing 
drug concentration, the complex formation of protein adducts increased 
compared to low drug concentrations, and major structural changes were 
observed as the incubation time progressed. The altered CIEF profile 
demonstrated the possible conformational changes due to the binding of the 
drug. Results also showed a significant protein pI shift for higher HSA-
oxaliplatin incubation ratios. Furthermore, the interaction of HSA with 
oxaliplatin was also confirmed by ultraviolet-visible (UV/Vis) absorbance and 
fluorescence quenching spectroscopy. Spectroscopic evidence shows that 
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oxaliplatin caused the fluorescence quenching of HSA by formation of HSA-
oxaliplatin complex. Using the Stern-Volmer equation, the quenching constants 
were calculated in the linear range. The quenching rate constants Kq at three 
different temperatures indicated that the quenching was initiated by static 
quenching.  
       Finally, a simple but effective approach was developed to characterize 
proteins including measuring pI and molecular mass. The approach combines 
CIEF, which separates proteins according to their pI, with dynamic imaging 
detection, which permits monitoring of protein diffusion in real time and 
thereby allows estimation of molecular weight from its diffusion coefficient. 
While yielding accuracy comparable to that of 2D-GE, this technique has 
several significant advantages, including speed (10-30 min per run) and ease of 
operation and automation. To test this approach, 16 proteins and peptides with 
molecular weights from 295 to 272 000 were chosen as test proteins.  The 
diffusion coefficients and pI values of these proteins were determined under 
identical conditions.  This simple technique can be applied to more complicated 








 7.2 Future Studies 
The work present here lays the ground work for the new path of   
investigating ligand-protein interactions using two different techniques. As 
already stated in chapter 1, the Raman technique is a fast analysis technique that 
requires only small sample volumes with almost no interference from water. 
Raman spectroscopy is a powerful tool for investigating chemical composition 
and molecular structure. However, the major limitation of conventional Raman 
spectroscopy is its low sensitivity due to the inherently low efficient scattering 
process. One technique, which overcomes these difficulties, is surface enhanced 
Raman spectroscopy (SERS). The unique ability to obtain molecular 
recognition of an analyte at very low concentrations in situ in aqueous 
environments using SERS and surface enhanced resonance Raman scattering 
(SERRS) detection makes these spectroscopies of considerable interest.  
Further work on the coupling of LCW-CIEF and LCW-SPME is 
essential for studies of proteins and protein-ligand interactions. Furthermore, the 
detection of single molecules can be achieved by using SERS active 
nanoparticles, coupled with CIEF or Laser induced fluorescence (LIF). A 
logical progression would be to conduct experiments under physiological 
concentrations for protein-drug interactions in order to study the action of the 
drug at the single molecule level.  
 
Finally, the mechanism of transport of oxaliplatin or cisplatin into 
erythrocytes to form Hb adducts is, however, not known. Thus, further studies 
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are necessary to investigate how oxaliplatin or cisplatin transported into 
erythrocytes to form Hb adducts. To accomplish this task, nanotubes have been 
suggested as a promising technique to transport the drug to the target site.  
Using this technique, nanotubes can be used as a drug carrier and the adducts 
formation between the drug-protein and drug-protein-nanotubes can be 
investigated by Raman spectroscopy. Furthermore, SERS active metal particles 
can be used to enhance the Raman signal of single adducts molecule formed 
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